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Inflammation Promotes Pneumococcal Colonization of the Respiratory Tract
Abstract
Inflammation is a critical host response to a range of potentially harmful stimuli, but it must be tightly
controlled in the respiratory tract to maintain the gas-exchange function of the lungs. Mucosal
inflammation in the upper respiratory tract, however, is a common response to multiple types of microbial
exposures. Some pathogenic bacteria, such as Streptococcus pneumoniae (the pneumococcus), can
colonize and persist in the face of these host responses, and can even promote inflammation, raising the
question of whether pneumococci evolved to take advantage of inflammation. Here, we examined the
hypothesis that airway inflammation promotes pneumococcal colonization, specifically by accelerating
bacterial growth, delaying pneumococcal clearance and enhancing bacterial transmission. To study how
inflammation promotes bacterial growth, we developed a novel flow cytometric assay using fluorescence
dilution to measure the replication of individual bacteria in vivo. Using a mouse model of influenzapneumococcal coinfection, we found that the host response to influenza infection includes secretion of
mucins, which are heavily decorated with sialic acid, onto the mucosal surface. Pneumococci that could
catabolize sialic acid were able to exploit this inflammatory response, as seen by increased bacterial
density in the airway and accelerated bacterial replication. Next, we examined whether overly exuberant
inflammation altered pneumococcal colonization. We found that infant mice tonically expressed high
levels of monocyte chemoattractants in the upper respiratory tract, and could not appropriately
upregulate these chemokines during colonization. Infants were unable to recruit monocytes, which
differentiate into macrophages, the effector cells of clearance, into the nasopharynx, and therefore could
not clear carriage as quickly as adult mice. Ectopic overexpression of one such chemokine, CCL2,
rescued the infant defects in macrophage trafficking and pneumococcal clearance. Finally, we studied
bacterial transmission in the presence of influenza-mediated inflammation in infant mice. Transmission
required influenza infection, and was increased in the absence of certain host signals that redirected the
inflammatory response. Together, these data demonstrated that inflammation alters three key aspects of
pneumococcal biology: early growth to establish colonization, immune evasion to avoid clearance and
transmission.
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ABSTRACT

INFLAMMATION PROMOTES PNEUMOCOCCAL COLONIZATION OF THE
RESPIRATORY TRACT

Steven J. Siegel
Jeffrey N. Weiser

Inflammation is a critical host response to a range of potentially harmful stimuli,
but it must be tightly controlled in the respiratory tract to maintain the gasexchange function of the lungs. Mucosal inflammation in the upper respiratory
tract, however, is a common response to multiple types of microbial exposures.
Some pathogenic bacteria, such as Streptococcus pneumoniae (the
pneumococcus), can colonize and persist in the face of these host responses, and
can even promote inflammation, raising the question of whether pneumococci
evolved to take advantage of inflammation. Here, we examined the hypothesis
that airway inflammation promotes pneumococcal colonization, specifically by
accelerating bacterial growth, delaying pneumococcal clearance and enhancing
bacterial transmission. To study how inflammation promotes bacterial growth,
we developed a novel flow cytometric assay using fluorescence dilution to
measure the replication of individual bacteria in vivo. Using a mouse model of
influenza-pneumococcal coinfection, we found that the host response to influenza
iii

infection includes secretion of mucins, which are heavily decorated with sialic
acid, onto the mucosal surface. Pneumococci that could catabolize sialic acid were
able to exploit this inflammatory response, as seen by increased bacterial density
in the airway and accelerated bacterial replication. Next, we examined whether
overly exuberant inflammation altered pneumococcal colonization. We found
that infant mice tonically expressed high levels of monocyte chemoattractants in
the upper respiratory tract, and could not appropriately upregulate these
chemokines during colonization. Infants were unable to recruit monocytes, which
differentiate into macrophages, the effector cells of clearance, into the
nasopharynx, and therefore could not clear carriage as quickly as adult mice.
Ectopic overexpression of one such chemokine, CCL2, rescued the infant defects
in macrophage trafficking and pneumococcal clearance. Finally, we studied
bacterial transmission in the presence of influenza-mediated inflammation in
infant mice. Transmission required influenza infection, and was increased in the
absence of certain host signals that redirected the inflammatory response.
Together, these data demonstrated that inflammation alters three key aspects of
pneumococcal biology: early growth to establish colonization, immune evasion to
avoid clearance and transmission.
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CHAPTER 1:
Introduction: Mechanisms of Bacterial Colonization of the
Respiratory Tract

Steven J. Siegel

Department of Microbiology, University of Pennsylvania, Philadelphia, PA,
19104, USA
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Introduction
Acute respiratory tract infections are a major source of disease worldwide, with
pneumonia alone responsible for more than 1.3 million child deaths annually
(166). Among the most frequent causes are bacterial infections with
Streptococcus pneumoniae (the pneumococcus), Haemophilus influenzae and
Staphylococcus aureus. Common to all these pathogens, as well as other
opportunistic invaders of the respiratory tract, is the requirement for bacterial
colonization to precede disease. Colonization is the process by which microbes
establish a presence and replicate within or on a host. Clinically unapparent,
carriage is the prerequisite to both local and systemic disease with many of these
opportunistic pathogens (19, 56, 65).

Upper respiratory tract colonization is not only the source of disease, but also
drives the evolution of these pathogenic microbes. Transmission to new
susceptible hosts occurs from the reservoir of bacteria colonizing the
nasopharynx, rather than from invasive infections (19, 65). As a result, the
demands of colonization drive the selective pressures that drive pathogen
evolution and virulence (262). Colonizing bacteria must avoid a range of host
challenges, from penetrating the mucus barrier to evading professional
phagocytes and obtaining a source of nutrients on the harsh mucosal surface.
These essential activities are summarized in the stages of colonization: bacterial
acquisition and attachment to the epithelial lining, obtaining nutrients and
2

replication, persisting in the face of the host immune response, and transmission
to a new host. Here, I review the mechanisms underlying each of these steps. I
focus on colonization by opportunistic pathogens that have the potential to cause
disease, rather than bacteria that are exclusively commensal in their relationship
with the host. Most notable among these, and most well-studied, is the
pneumococcus. I also focus on evidence from in vivo experimental models.
Though these studies have largely been performed in rodents, with some work in
humans and non-human primates, these manipulable models provide
mechanistic information. I highlight the broad themes and commonalities shared
by many of these opportunistic pathogens that colonize the nasopharynx as the
first step in pathogenesis.

Acquisition and Attachment
Stably colonizing the nasopharynx requires passing through the protective mucus
layer to reach the epithelial surface, lest colonizing bacteria be rapidly swept away
by mucociliary clearance (60). So important is remaining on the epithelial
surface, at least until the time of transmission, that opportunistic pathogens of
the airway have developed multiple strategies for attachment, in three broad
categories: associations with mucus, weak association with host carbohydrates,
and strong association with host surface proteins.

3

The importance of mucus in protecting against bacterial colonization was
demonstrated by experimental colonization of ferrets with Staphylococcus
aureus. Early after inoculation, nearly all staphylococci were predominantly
found in the mucus gel layer, rather than bound to epithelial cells (207). While
some bacteria may bind to glycoconjugates in the mucus layer, others exit it to
reach the epithelial surface by repelling anionic mucus with a negatively-charged
polysaccharide capsule (160). Using capsule to pass through mucus, however,
complicates attachment to the epithelium, as the thick polysaccharide capsule
also repels host cells. Airway colonizers have evolved multiple mechanisms of
phenotypic variation to adjust to different microniches during carriage.
Pneumococci, for example, undergo phase variation, or rapid on-off switching,
between opaque and transparent colony morphologies. Opacity is a reflection of
bacterial-bacterial interaction, and differences stem from cell surface changes
that affect these associations. Opaque variants display more capsule but less
teichoic acid and other adhesins such as PspC (CbpA) (98). Only transparent
variants could effectively colonize infant rats (98). Opacity variation, while
leading to the emergence of more virulent highly encapsulated organisms during
sepsis, could in the nasopharynx serve to promote exit from mucus (highly
encapsulated opaque variants) and then binding to the epithelium (transparent
variants without as much capsule blocking adhesin interactions). LPS
modifications causing opacity variation also contributed to colonization of infant
rats by Haemophilus influenzae (261). Not all bacteria need to downregulate
4

capsule to bind the epithelial surface stably, however. The hyaluronic acid
capsule of Streptococcus pyogenes binds CD44 on host cells, particularly during
the first 45 minutes after acquisition (44).

The second stage of attachment is thought to involve weak attachment by
bacterial lectin-like proteins to host surface carbohydrates (250). Studies of the
chinchilla airway demonstrated that pneumococcal colonization led to
desialylation that was dependent on expression of the bacterial neuraminidase
NanA. A nanA mutant was unable to colonize chinchillas, indicating that sialic
acid cleavage was important either to exit the heavily sialylated mucus or to
reveal host cell receptors (237). The effect of neuraminidase may be animal
model-dependent, however, as other work found no effect during colonization of
infant rats (100). In vitro, the exoglycosidase BgaA binds specific host surface
carbohydrate residues (221).

More stable adherence comes through interaction with host cell surface proteins
(250). Pili are important for adhesion and colonization for pneumococci, (15) H.
influenzae, (91) and Moraxella catarrhalis (122). Pili are not always the adhesive
factor, though. In pneumococci, RrgA is a pilus-associated adhesin that was
required for adhesion, in both the presence and absence of pili (158). Pili may aid
in extending adhesins beyond the capsule to allow for binding to the host (158).
Another pneumococcal adhesin is PspC (CbpA), which binds secretory
5

component on the polymeric immunoglobulin receptor (167). Fibronectinbinding proteins PavA and PavB were also important during pneumococcal
colonization (88, 92). The filamentous hemagglutinin (FHA) of Bordetella
species has been implicated in adherence in vivo as well. In B. bronchiseptica,
FHA was necessary for colonization of mice, and is one of the most highly
expressed genes in Bvg+ Bordetella, the phase of growth when virulence genes
are expressed under the control of the BvgAS two-component system (43).
Ectopic expression of FHA during the Bvg- phase was not sufficient to promote
adherence in vivo, (43) underscoring the importance of tight control over adhesin
expression for effective colonization. Similarly, pilus expression in pneumococci
appears to be regulated, as it is highest during the early phases of murine
colonization (172).

Adhesins in S. aureus follow a similar pattern of modulated expression. Wall
teichoic acids on the S. aureus cell surface was required for colonization of cotton
rats, (259) binding to the nasal cavity surface receptor SREC-I (16). Clumping
factor B (ClfB) was necessary for experimental human colonization, and binds
cytokeratin 10 in vitro (263). More recent work using knockout mice and
bacterial mutants demonstrated that the receptor for ClfB was not cytokeratin 10
but rather loricrin, a protein found on the cornified envelope of the squamous
epithelium in the anterior nares, the site of S. aureus colonization (154). ClfB was
not only necessary but sufficient when exogenously expressed in Lactococcus
6

lactis to allow for adherence and colonization of wildtype, but not loricrindeficient, mice (154). These results emphasize the importance of in vivo studies,
as in vitro studies did not identify the relevant ligand-receptor interaction
necessary for colonization. Using cotton rats, wall teichoic acids were found to be
expressed in vivo early during colonization, replaced over time by ClfB and the
adhesin IsdA (29). Adhesins were also expressed in colonized humans, coinciding
with a lack of expression of the agr virulence regulatory system (30).

Growth and Nutrient Sources
After establishing a stable presence on the mucosal surface, colonizing organisms
must find a source of nutrients to promote replication. Growth during
colonization amplifies bacterial density, potentially increasing the likelihood of
transmission to the next host. Proliferation is particularly challenging in the
nasopharynx, however. Free carbohydrates are not detectable in the normal,
uninflamed upper respiratory tract, (182) and the host actively depletes glucose
from the airway surface fluid as a form of nutritional immunity, limiting access to
a carbon source as an antimicrobial strategy (181).

The difficulties of replicating in the nasopharynx were made clear by a recent
study that used transposon mutagenesis of pneumococci and the method Tn-seq
to catalog the genes necessary in different host and in vitro environments (245).
The nasopharynx was the “harsher” microniche, as genes that were required in
7

both the upper and lower respiratory tracts showed larger average fitness defects
when absent in the nasopharynx, suggesting that these genes were more
necessary during colonization than pneumonia (245). Using dilution of a
temperature-sensitive, antibiotic resistance-expressing plasmid, pneumococcal
doubling times were calculated for replication in the mouse nasopharynx (161
min) and lungs (108 min), suggesting nutrients are less readily available in the
site of initial colonization (245). This doubling time was consistent with results
obtained using a flow cytometric method to quantify the dilution of CFSE, a
fluorescent dye commonly used for eukaryotic cell division tracking, from
pneumococci colonizing the mouse upper respiratory tract (S.J. Siegel & J.N.
Weiser, unpublished data). Influenza coinfection accelerated CFSE dilution, and
therefore replication, by providing a carbon source via mucin secretion (219).

Pneumococci are dependent on carbohydrates as a source of carbon for growth,
and are particularly adept at accessing them on the airway surface. Among
commensal and pathogenic bacteria that colonize the upper respiratory tract,
pneumococci express the most diverse array of sugar transporters and utilization
genes (28). More than 30% of transporters in the pneumococcal genome were
predicted to import carbohydrates as substrates, a higher proportion than any
other bacterium sequenced (234). By contrast, H. influenzae and N. meningitidis
had few carbohydrate transporters (234). Most of the carbon metabolism genes
in Escherichia coli have been lost in H. influenzae (233). Pneumococcal
8

colonization independently requires catabolism of sialic acid, (130, 238),
hyaluronic acid (131) and sucrose or a related disaccharide (85). It also requires
an ATPase to energize multiple ABC transporters used for sialic acid, raffinose
and maltotetraose (129). This wide range of transporters and sugars that can be
used does not reflect redundant pathways, however, as suggested by the
decreased colonization seen with any individual mutation (28). Rather, each
transporter may be important in specific microenvironments encountered during
colonization or in certain hosts, such as the particular importance of sialic acid
during colonization following influenza, a viral infection that provides excess
sialylated mucins to pneumococci (219).

Other opportunistic pathogens of the airway use additional sugars during
colonization, though in vivo evidence is more lacking. N. meningitidis required
lactate permease to utilize this carbon source in vitro and to grow in
nasopharyngeal explants (58). Sialic acid catabolism was not required for H.
influenzae to colonize the infant rat, though sialylation of the bacterial surface
contributed to immune evasion (248). During experimental S. pyogenes
pharyngitis in macaques, microarray analysis revealed high levels of maltodextrin
and mannose catabolic gene expression in bacteria early during colonization
(249). A maltodextrin-binding protein was required for S. pyogenes to colonize
the mouse oropharynx (213). A transcriptional repressor in the same operon was
also necessary for colonization, implying that tight regulation of carbohydrate
9

utilization genes is important during carriage (212). Similarly, the nutritional
repressor CodY was required during pneumococcal colonization, and its
transcript was expressed in vivo in the nasopharynx (74). These modes of
regulation imply there may be a temporal switch during colonization between
rapid replication to a later, more silent phase of quiescently persisting in the host.

Nearly all bacteria, including all opportunistic pathogens of the airway, must
obtain a source of iron to survive (260). The host has developed mechanisms to
combat this essential microbial activity by sequestering iron or targeting bacterial
uptake mechanisms (260). These mechanisms are active in the nasopharynx, as
evidenced by the high levels of isdA expression in S. aureus colonizing the human
airway (30). Expression of this tightly iron-regulated gene implies S. aureus is
growing under iron-limited conditions in vivo (30). One bacterial strategy to
acquire iron is secretion of siderophores, low molecular weight proteins that bind
iron with high affinity (260). Respiratory colonizers, including pneumococci, H.
influenzae and N. meningitidis, tend not to secrete siderophores and instead
obtain iron by directly retrieving iron-containing molecules such as lactoferrin,
transferrin, hemin and hemoglobin (159, 231, 260). This strategy may have
evolved to avoid host anti-siderophore defenses, which includes secretion of
lipocalin-2 (siderocalin) that bind siderophores to prevent their uptake by
bacteria (159, 260). Lipocalin-2 was induced in the murine nasopharynx during
colonization with pneumococci and H. influenzae, as well as in the human nasal
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mucosa, raising the possibility that these bacteria were actively inducing a host
response that could eliminate competitors without being susceptible themselves
(159). S. aureus and Bordetellae produce siderophores that are structurally
distinct from enterobactin and, as a result, can evade lipocalin-2 (159). The
precise in vivo importance of many of these iron acquisition mechanisms has not
been tested in nasopharyngeal colonization, but the pneumococcal lactoferrinbinding protein PspA was found to be outcompeted by wildtype bacteria in an
infant rat model (135). Pneumococci lacking pspA could still experimentally
colonize humans, however (135). S. aureus colonization of the infant rat airway
was enhanced by the presence of hemoglobin (188).

Nutritional immunity extends to other transition metals, particularly zinc and
manganese, additional critical cofactors for many bacterial functions (95).
Pneumococci obtain both zinc and manganese via the PsaA protein, but excess
zinc can be toxic to colonizing bacteria and can compete with manganese for
uptake by pneumococci (144). The ratio of Zn2+ to Mn2+ becomes elevated in the
nasopharynx during pneumococcal colonization, suggesting the host is actively
increasing zinc or limiting manganese to combat incoming bacteria (144).

Immune Evasion and Persistence
The mucosal surface is harsh not only because of scarcity of resources. From the
time of acquisition, colonizing bacteria interact with and must evade the host
11

mucosal immune system. For bacteria without an animal or environmental
reservoir, avoiding clearance by the immune system is a necessary step to persist
long enough to spread to susceptible hosts. Bacteria have evolved a range of
strategies to evade the different branches of the host response. Innate responses
can be actively thwarted by specific effectors that target host cells, or bacteria can
evade detection by shielding themselves with host-mimicking molecules. Rapid
transmission can also be thought of as an evasion strategy, as exit to a new host
can occur before the onset of adaptive immunity.

Bacterial contact with the immune system begins on entry into the nasopharynx,
where colonizers are met by the layer of mucus that coats the upper respiratory
tract. Mucus itself is antimicrobial, providing a physical barrier bacteria must
traverse to reach host cells. Bacteria trapped within it are also removed by
mucociliary clearance. Additionally, mucins serve as a scaffold for antimicrobial
proteins (60). So important is the mucus barrier to infection that the primary
virulence factor common to many opportunistic pathogens of the URT, capsular
polysaccharide, may have evolved to combat it. While capsule is well-known for
its role in limiting opsonophagocytic killing in serum, it also contributes to
evading mucus-mediated clearance. Unencapsulated pneumococci were inhibited
in early colonization of mice compared to isogenic bacteria expressing a capsule
(160). Each of the >90 pneumococcal capsule types is either uncharged or
negatively charged, allowing for repulsion from the anionic mucus barrier. The
12

lack of colonization without capsule was not due to increased susceptibility to
neutrophils, complement or antibody, and unencapsulated mutants were
observed to remain stuck in mucus rather than reaching the nasopharyngeal
epithelium (160).

Even without capsule, successful respiratory tract colonizers have alternative
methods to resist antibody-mediated clearance. Pneumococci, Neisseria and H.
Influenzae all encode a protease specific to human immunoglobulin A1 (IgA1),
the dominant IgA present on the respiratory tract and in serum. In vitro, these
proteases cleave IgA1, retaining Fab fragment binding to the bacterial surface but
preventing antibody effector functions by removing the Fc fragment (185). Mice
passively immunized with human IgA1, but not IgA2, were protected from
intranasal infection with IgA protease-producing, but not IgA protease-deficient,
pneumococci (86). Other bacteria do not effectively evade humoral immunity.
Clearance of Bordetella pertussis, and the related species Bordetella
parapertussis and Bordetella bronchiseptica, was delayed in mice lacking
mature B cells (102).

Colonizing bacteria modify their cell surface to resist antibodies and other
mechanisms of targeting microbes for clearance. Phosphorylcholine (ChoP), a
constiuent of the surface of multiple respiratory tract bacteria, is poorly
immunogenic, as it mimics host structures including phosphatidylcholine found
13

in membrane lipids. For example, ChoP modifies the lipopolysaccharide of nontypeable H. influenzae, preventing binding of bactericidal antibody by altering
accessibility to underlying bacterialal antigens (38). During colonization,
adaptive immunity was required to select for ChoP expressing NTHi, a process
that occurs through phase variation, the rapid switching of a choline kinase gene
on or off through slipped strand mispairing in a repetitive DNA motif (38). LPS
biosynthetic gene phase variation has also been observed during experimental
human colonization (187). In a different form of genetic regulation, the LPS of B.
bronchiseptica is modified by pagP, a palmitoyl transferase that is under the
control of the BvgAS two-component system that regulates virulence gene activity
(184). These LPS modifications allow for evasion of antibody-dependent
complement-mediated lysis (184).

After transiting the mucus layer, colonizing bacteria reach the epithelial surface,
where they are rapidly sensed by multiple innate pattern recognition receptors
that contribute to clearance. Lipoteichoic acids of pneumococci (246) and S.
aureus (63) are sensed by Toll-like Receptor (TLR) 2, while lipoproteins and
lipopolysaccharide from H. influenzae can be recognized by TLRs 2 and 4,
respectively (272). TLR4 has also been described to recognize the pneumococcal
pore-forming toxin pneumolysin (127). In addition to surface receptors, these
predominantly extracellular pathogens are also sensed by host cytosolic detectors
that contribute to clearance, such as nucleotide-binding oligomerization domain
14

(Nod) receptors that sense peptidoglycan from bacterial cell walls. Signals from
Nod1, which recognizes gram negative peptidoglycan, are important in
controlling H. influenzae carriage, (272) while Nod2, which senses peptidoglycan
fragments from both gram positive and gram negative bacteria, is necessary to
clear pneumococcal colonization (49). Further in vivo evidence of intracellular
sensing of extracellular pathogens stems from findings that type I interferons are
produced during pneumococcal colonization and required for clearance of the
organism (175). Other work has shown, however, that synergistic, larger increases
in type I IFN during influenza-pneumococcal coinfection impairs pneumococcal
clearance (156).

The initial response to colonization with a range of opportunistic pathogens is
generally a mild suppurative rhinitis which can often be subclinical and
inapparent, but reflects infiltration of neutrophils into the nasopharynx (3, 63,
246, 272). For many respiratory tract colonizers, this initial influx is insufficient
to clear colonization, either because the phagocytes are ineffective at clearing
these encapsulated microbes prior to antibody development, or since the bacteria
actively evade neutrophil-mediated killing (134). The adenylate cyclase toxin of B.
bronchiseptica, for example, inhibits neutrophil effector functions by inducing
cAMP overproduction from ATP, allowing the bacteria to avoid mucosal
clearance (71, 147).

15

Neutrophils are inadequate for pneumococcal clearance in the upper respiratory
tract, but cellular and adaptive immunity is still required (246). CD4 T cells are
necessary and sufficient to provide acquired immunity to secondary
pneumococcal challenge. IL-17A is also required to immunize against
pneumococcal colonization, and mice deficient in the IL-17A receptor also cannot
control primary colonization (121). Sensing of pneumococci by TLR2 is required
to induce Th17 responses, which lead to macrophage recruitment into the
nasopharynx. These macrophages are the effector cells of pneumococcal
clearance, as demonstrated by depletion experiments with clodronate liposomes
(271). Th17 and macrophage responses are also dependent on intracellular
signaling through Nod2, which additionally leads to production of the
macrophage/monocyte chemoattractant CCL2 (49). CCL2 sensing by its receptor
CCR2 leads to increased clearance of carriage. Pneumolysin pore formation is
also required in vivo for Ccl2 expression, suggesting a potential mechanism for
access of pneumococcal products to cytosolic sensors. Lysozyme, which digests
peptidoglycan to generate fragments for Nod2-dependent signaling, is also
required for these effects on clearance (49). Pneumococci have enzymatic
mechanisms to limit lysozyme by modifying peptidoglycan structure to avoid lysis
(48).

Consistent with their resistance to opsonophagocytic killing in the airway,
pneumococci are cleared by nonopsonic receptors. MARCO expression, though
16

not directly responsible for pneumococcal uptake by macrophages, is necessary
for monocyte and macrophage recruitment, Ccl2 upregulation and clearance of
pneumococcal carriage (54). Macrophage migration inhibitory factor is also
required during pneumococcal colonization for the sustained presence of
macrophages, Ccl2 upregulation and clearance (46). Expression of the microRNA
miR-155 also contributes to Th17 induction and macrophage recruitment during
pneumococcal carriage (247). B. pertussis protection from whole cell vaccination
is mediated by IL-17, (77) and colonization of baboons, a more natural model
than rodents, leads to Th17 induction and downstream effector production, such
as neutrophil chemoattractants (256). Acellular pertussis vaccination that
induced Th1 immunity instead of Th17 did not protect against carriage in
baboons, (258) suggesting the importance of Th17 responses in clearing B.
pertussis.

Paradoxically, macrophage recruitment and eventual clearance requires
pneumococcal expression of pneumolysin (46). It may seem counterintuitive for
a colonizing organism to induce the specific host response that clears it, but it is
possible that persistence in the respiratory tract is sacrificed at the expense of
inducing a more robust inflammatory response, which could promote
transmission to a new host (262). Early during colonization, pneumolysin
promotes higher bacterial density (93) and increased neutrophil influx (134) in
the nasopharynx, supporting this possibility.
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While Th17 responses seem to be broadly conserved in clearance of airway
colonizers, the effector mechanisms by which IL-17 acts can vary by pathogen.
For S. aureus, clearance of carriage required T cells and IL-17A, which promoted
recruitment of neutrophils, not macrophages, into the nasal lumen. Neutrophils
were required for clearance, though IL-23 was not needed to amplify IL-17A
responses, which may have been driven by IL-1! secretion instead (9). Other
work demonstrated that unencapsulated S. aureus are cleared faster from the
nasopharynx, but only after the first week postinoculation (103). This timepoint
coincides with the influx of neutrophils into the nasopharynx, (9) suggesting that
the S. aureus capsule resists neutrophil-mediated killing in the nasopharynx.

Modifiers: Host, Competitors, Coinfections
The balance between host and colonizer can be tipped in either direction by a
range of factors that modify each of the previously described stages of
attachment, growth and immune evasion. Both congenital and acquired
immunodeficiencies can predispose to disease caused by the encapsulated
pathogens that colonize the respiratory tract. These conditions, such as
deficiencies in signaling downstream of TLRs and IL-1 receptor (IRAK-4
deficiency) or lack of a functional spleen, lead to higher rates of invasive disease,
particularly with pneumococci (32). For many of these diseases, the time of
greatest susceptibility to invasive pneumococcal disease is during early
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childhood, a period during which >50% of even healthy children are colonized
with pneumococci (183). It is unclear, therefore, to what extent the
immunodeficiencies that cause excess pneumococcal disease are also responsible
for promoting bacterial colonization. In mice, deficiencies in MyD88, a signaling
adapter upstream of IRAK-4, caused increased susceptibility to both invasive
disease and higher density of pneumococcal carriage in the nasopharynx (4). Less
dramatic but still important in causing disease is the age of the host as a
determinant of disease. Both colonization and invasive disease occur largely in
young children, and mice colonized with pneumococci as infants take longer to
clear the bacteria (21). In aged mice, pneumococcal clearance is also slower than
in young adult mice, and was associated with decreased influx of macrophages,
the effector cells of clearance (110).

Opportunistic pathogens colonizing the respiratory tract compete with a range of
other bacteria, starting with the pre-existing commensal flora. Although the
mechanisms remain unknown, bacteria adapted to particular hosts seem to be
more capable of displacing that host’s microbiota. B. bronchiseptica, which can
naturally colonize mice, could replace the cultureable mouse nasopharyngeal
flora after inoculation of <100 colony forming units (CFU). Stable colonization of
mice with B. pertussis, a human adapted pathogen, required a more than 100fold higher inoculum, and still could not displace the mouse flora. Local
antibiotic treatment to deplete commensal bacteria lowered the required
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infectious dose of B. pertussis to <100 CFU, though a single commensal mouse
species could inhibit colonization even in antibiotic-treated animals (264). At
least one commensal bacterium has the ability to fight back against opportunistic
colonizers. Staphylococcus epidermidis can secrete a serine protease, Esp, and
doing so allows S. epidermidis to inhibit S. aureus carriage, (84) potentially by
inhibiting biofilm formation or cleaving adhesins. In experimental colonization of
humans, pre-existing S. aureus carriage was cleared by inoculating Espexpressing S. epidermidis or purified Esp protease (84).

Other opportunistic colonizers pose a competitive threat to the encapsulated
extracellular pathogens of the airway. Pneumococcal carriage is associated with a
lower risk of S. aureus colonization in children, (193) but many of the
mechanisms proposed for this negative interaction in vitro have not been verified
in experimental in vivo models. These two species occupy different niches within
the airway, the posterior nasopharynx and anterior nares, respectively,
suggesting that these bacteria may not directly compete. Instead, the host
immune system mediates competition (116). Prior pneumococcal colonization of
mice protected against secondary challenge with S. aureus, in an antibodydependent manner. Pneumococcal colonization elicited antibodies that crossreact with S. aureus, and antibodies to a specific pneumococcal protein that could
also target a specific S. aureus protein were necessary and sufficient to protect
against S. aureus carriage (116).
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Another immunologic mechanism has been described mediating the negative
interaction between colonizing pathogens. Co-colonization of mice with H.
influenzae and pneumococci led to synergistic increases in neutrophil
chemoattractant production and neutrophil influxes, in a manner dependent on
production of the pneumococcal pore-forming toxin pneumolysin (191). This
increased recruitment of neutrophils was required, along with complement, for
opsonophagocytic clearance of pneumococci during co-colonization, while H.
influenzae persisted (124). Neutrophils had to be activated by Nod1-mediated
recognition of H. influenzae peptidoglycan to promote pneumococcal clearance
(123). One colonizing organism, H. influenzae, was able to effectively outcompete
another by inducing an immune response that it could evade, using the host
instead of directly targeting other bacteria. This process has been referred to as
“within host competition” (24).

Direct interactions can occur within one species as well. For instance,
pneumococci express bacteriocins in vivo, and can use these antimicrobial
peptides to outcompete pneumococcal strains that lack the cognate immunity
protein (50). Pneumococci can also benefit from other co-colonizing strains,
however, due to their natural ability to take up and recombine DNA, to be
transformed. Rates of transformation in vivo were ~107-fold higher during
murine colonization than during planktonic growth during sepsis (132). Transfer
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of antibiotic resistance occurred at such a high rate even without selective
pressure from antibiotic exposure, suggesting that colonization provides
pneumococci with ample opportunity to obtain new genetic material and benefit
from co-colonization with the same or closely related species (132).

Coinfection with viral pathogens also influences bacterial colonization of the
airway. The most well-understood of these interactions is influenza viral infection
predisposing to pneumococcal disease (139). Multiple mechanisms have been
proposed for how influenza increases susceptibility to pneumococcal pneumonia,
with more limited work addressing how influenza might alter colonization, the
prerequisite to pneumonia. Early work focused on influenza leading to a denuded
airway epithelium, promoting increased bacterial adherence to the trachea and
lungs, (79, 186) but increased adherence is not required for influenza to promote
secondary bacterial disease (148). Coinfection leads to synergistic increases in
type I IFNs that decrease CCL2 induction and prevent macrophage recruitment
to the upper respiratory tract, limiting pneumococcal clearance, providing an
immunologic explanation for this interaction (156). Influenza can also provide a
nutrient source to colonizing pneumococci. A flow cytometric assay
demonstrated that influenza specifically promoted increased bacterial replication
in vivo during coinfection (219). Host recognition of influenza leads to increased
secretion of Muc5ac, an airway mucin that is heavily sialylated. Pneumococci
exploit this influenza-provided sialic acid from mucins to accelerate growth in
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vivo (219). Influenza also predisposes to murine colonization with H. influenzae
(79) and S. aureus, (150) the two most common pathogens found in postinfluenza disease, after pneumococci (139).

Progression to Disease
While not a conserved step in carriage, potentially pathogenic bacteria that first
colonize the airway can cause a range of local and systemic disease. Whether
disease stems from direct spread from the nasopharynx or active invasion, these
processes do not promote spread to new susceptible hosts, and therefore do not
exert selective pressure on these organisms (94, 262). The demands of
colonization, however, lead to the development of virulence factors that
contribute to disease (262).

These organisms most frequently cause acute otitis media and sinusitis,
stemming from direct spread of pneumococci or non-typeable H. influenzae (12,
94). Viral infections, particularly due to influenza or respiratory syncytial virus,
often precede bacterial otitis media, and experimentally have been shown to
predispose humans and model organisms to this disease (12, 141, 215). These
viruses alter mucociliary clearance by inhibiting ciliary beating, (12) limit
neutrophil antibacterial functions, (1) and decrease middle ear pressure to
promote direct bacterial spreading (26). The inflammatory response to influenza
also promotes higher pneumococcal density in the middle ear, independent of the
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number of bacteria in the nasopharynx (216). Pneumococcal opacity variation
that develops during colonization also influences progression to acute otitis
media. Opaque variants are selected for in the transition from the nasopharynx to
the middle ear, both in humans and animal models (8, 236).

Local spread within the respiratory tract can also extend into the lungs, causing
pneumonia. Bacteria colonizing the nasopharynx can be aspirated into the lower
respiratory tract, and higher density of pneumococcal carriage has been
associated with increased risk of pneumonia (5). It was not clear in these human
studies, however, whether the increased bacterial load in the upper airway
preceded or followed pneumonia. Experimental colonization of mice followed by
bronchoalveolar lavage revealed that higher nasopharyngeal density correlated
with increased numbers of bacteria in the lungs (219). Influenza infection also
predisposes to pneumococcal pneumonia by increasing bacterial adherence and
inhibiting antibacterial innate immune defenses in the lung (139, 148).

Bacteremia and subsequent sepsis develops in a proportion of bacterial
pneumonias, though colonizing opportunistic pathogens can also directly seed
the bloodstream in a process termed occult bacteremia (94). Type I interferons
oppose bacterial invasion from the lungs by enhancing tight junction protein
expression and limiting lung permeability (111). Pneumococcal binding by the
PspC (CbpA) adhesin to the polymeric immunoglobulin receptor (pIgR)
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contributes to invasion, as mice without a functional pIgR had delayed
bacteremia following pneumonia (270). Invasion directly from the colonizing
reservoir in the nasopharynx occurs via common pathways. TLR-mediated
recognition of pneumococci and H. influenzae leads to p38 MAPK and TGF-!
activity, which decreases claudin expression and promotes epithelial opening,
promoting bacterial translocation (40). The transcriptional repressor SNAIL1 is
induced by TLR2 and TLR4 stimulation, and downregulates claudin expression
(17). LPS signaling through TLR4, even without bacterial colonization, is
sufficient to promote serum leakage onto the mucosal surface (17). Host sensing
of bacterial colonization promotes an inflammatory response that requires
epithelial opening to allow professional phagocytes to enter the nasopharyngeal
lumen. Encapsulated pathogens can exploit this patterned host response to
permit entry into the systemic circulation (40). Some pathogens have more
specific invasion strategies, such as S. pyogenes that transits the epithelium
through M cells, specialized cells that sample the lumen for antigens (174).
Invasion is not limited to pathogens, however, as viable Lactobacillus murinus
can be found in the nasal-associated lymphoid tissue (NALT). This commensal is
found at lower rates than S. pyogenes, however, implying either that pathogens
translocate more efficiently or persist in sterile sites more readily, or both (42).
While many bacteria may invade the bloodstream, a single surviving organism of
H. influenzae type b is sufficient to cause bacteremia (128). Similarly, during
intravenous infection of mice, a single pneumococcus persists to cause persistent
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bacteremia (62). Accessing the intracellular space can also promote persistent
colonization by avoiding immune-mediated clearance (226). Viable NTHi can be
found in human adenoid tissue and bronchial epithelium samples (226).

Much as only a small percentage of bacterial pneumonia will lead to persistent
bacteremia, only a small proportion of bacteremic patients will go on to develop
meningitis. The three historically most important bacterial pathogens of children,
the pneumococcus, H. influenzae and N. meningitidis, are all encapsulated and
can commonly cause meningitis (239). They all appear to cross the blood brain
barrier by interacting with the laminin receptor, using different adhesins: PspC
(CbpA) for pneumococci, the pilus PilQ and porin PorA for N. meningitidis, and
the outer membrane protein OmpP2 for H. influenzae (171). Other receptors
contribute to meningeal invasion, including CD46 that serves as the target for N.
meningitidis pili (89). The platelet activating factor receptor (PAFr) may
contribute to invasion at all steps from nasopharynx to lung to blood to brain
(189). A single organism that invades the bloodstream and persists is sufficient to
cause meningitis (153). Bacterial factors such as neuraminidase also contribute to
passage through the blood brain barrier, even without affecting bacterial
replication in the bloodstream (242). Invasion can also occur directly from the
nasopharynx. Olfactory epithelium overlies the posterior nasal cavity, and N.
meningitidis can extend up the olfactory nerve to access the meninges (222).
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Transmission
Comparatively little is known about the mechanisms underlying transmission of
bacteria in the upper respiratory tract. Spread from the reservoir of bacteria in
the nasopharynx to a susceptible host is a necessary part of the biology of those
microbes that can only grow within a host. For common respiratory tract
colonizers, survival on environmental surfaces can be for as little as 1 day, such as
with pneumococci, or as long as 7 months, as with S. aureus (109). The evolution
of bacteria that depend on animal hosts, therefore, is likely driven in large part by
the demands and constraints of transmission. Only recently have animal models
been developed to address this hypothesis.

While rodent models have been informative for mechanisms of bacterial
colonization and disease in the upper and lower airway, they are less productive
for studies of transmission. This failure in part stems from the larger bacterial
inocula needed to establish colonization in some rodent models of human
pathogens compared to natural infection. Mouse models of transmission of
respiratory pathogens are particularly limited, however, by a lack of effective
cough reflex, hampering airborne transmission that largely occurs by contact
with bacteria-containing droplets (151, 155). Recent work has relied on influenza
coinfection to potentiate pneumococcal transmission within litters of infant mice
(52). In this model, influenza infection leads to spread of established
pneumococcal colonization to new naive infant hosts, a process that occurs over a
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few days (52). Influenza increased pneumococcal titers in the directly inoculated
donor, or “index,” mice, (52) and increasing these bacterial numbers by
neutrophil depletion was sufficient to promote transmission to influenza-infected
recipient, or “contact,” mice (217). Earlier, more observational transmission
models in infant rodents for pneumococci (126) and H. influenzae, (69) suggest
that influenza is not absolutely required for transmission, however. Additionally,
other mouse models have suggested that higher bacterial titers in the donor mice
are not the driver of increased transmission with influenza coinfection (196).

Studies in rodents have focused on transmission among litters of suckling
infants, a scenario less relevant to human disease. H. influenzae, however, was
also transmitted among weaned rats, demonstrating that the presence of the dam
is not required for at least some transmission models (69). Other studies have
physically separated donor and recipient animals, demonstrating that airborne
transmission can occur without requiring direct contact (23, 142). However, even
for respiratory pathogens, direct contact with bacteria-containing droplets may
not always be required for transmission, as dessicated pneumococci could be
recovered and used successfully to colonize mice up to 4 weeks after drying on an
environmental surface (254).

Unlike mice, ferrets do sneeze, allowing for airborne transmission. A ferret model
of coinfection demonstrated influenza promoted increased pneumococcal
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colonization and transmission, and potentiated transmission over longer
distances (142). Higher bacterial density in the donor ferrets was not the
mechanism for increased transmission, as influenza infection also increased the
colonization density of a different pneumococcal strain that was not transmitted
to recipient ferrets (142).

Host pattern recognition receptors have also been implicated in transmission, as
Tlr2-/- mice had increased pneumococcal transmission during influenza
coinfection, and Tlr4-/- mice demonstrated increased B. bronchiseptica
transmission (196, 201). TLR expression in donor animals limited influenza titers
and bacterial shedding, and its absence was required for high levels of
transmission (196, 201). Adaptive immunity was not required to control
transmission, however (201).

The inflammatory response to colonization and coinfection stimulates
transmission, though precisely how is not yet understood. Inflammation from
LPS inoculation could substitute for influenza infection in recipient, but not
donor mice to promote transmission (217). In another model, TLR2 deficiency
that led to increased transmission was associated with increased shedding, a
more robust neutrophil influx and higher induction of the secreted airway mucin
Muc5ac (196). Increased mucin expression suggested a potential mechanism
underlying inflammation-induced transmission. In ferrets, influenza also
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promoted increased mucus secretions (142). Neutrophil influx to the
nasopharyngeal lumen resulted in increased mucus secretion in vivo, (70) which
could facilitate bacterial shedding and spread to new hosts. In B. bronchiseptica
transmission in pigs, however, expression of the Type III secretion system that
induces inflammation was not required for transmission, suggesting that not all
bacteria may take advantage of inflammation for transmission (163).

Bacterial factors underlying transmission are largely unknown. Using pigs as a
natural model, one study found that, surprisingly, transition between Bvg+ and
Bvg- phases was not required for B. bronchiseptica transmission, as Bvg+ phaselocked strains still transmitted equally well as wildtype bacteria (164). It is
possible that even this natural model of transmission did not accurately reflect
the time Bordetella must survive in the environment between hosts, a niche that
would require switching to the Bvg- phase (164). In Streptococcus pyogenes,
inactivation of the covR/S two-component regulatory system resulted in
decreased transmission, likely at the level of acquisition by the recipient mice (3).

A new model of Bordetella transmission by droplet employs baboons and B.
pertussis and recapitulates the essential clinical features of human pertussis
infection (257). This model was used to demonstrate that acellular pertussis
immunizations protect from infection, but not colonization or transmission, a
finding with important implications for vaccine design and public health (258).
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Conclusions
After being shed from a prior host, colonizing opportunistic pathogens enter the
nasopharynx, where they escape from mucus and attach to the epithelial lining.
These bacteria must obtain a source of nutrition on the spare mucosal surface in
order to replicate, and use multiple strategies to evade host clearance. The
bacterial factors elaborated during colonization can also predispose the host to
invasive disease. Ultimately, colonizing organisms that can adhere, grow and
evade clearance will transmit to a new susceptible host.

Many, and sometimes all, of these respiratory colonizers share similar strategies
for each stage of colonization. Phase variation of capsule influences acquisition,
immune evasion, invasion and potentially survival outside the host during
transmission (125, 160, 254). Expression of phosphorylcholine modifies the cell
surface of many airway pathogens and is crucial for attachment and immune
evasion (38, 226). The mucosal immune response to these pathogens has
commonalities, reflected by the presence of an IgA protease in multiple microbes,
as well as the Th17 response many elicit (9, 86, 271). These bacteria often produce
toxins to target the host, and typically benefit from coinfection with viruses,
particularly influenza (12, 94, 139). Both reflect the effects of inducing
inflammation at the expense of the commensal flora. Inflammation promotes
every stage of colonization, from upregulating receptors for adherence to
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providing a source of nutrition, misdirecting the immune response, increasing
the rate of invasion and facilitating transmission (19, 196, 216, 262).

The relevance of inflammation to each stage of carriage suggests potentially
pathogenic colonizers may have evolved to induce inflammation to drive
colonization and transmission (24). Colonization, rather than invasive disease, is
the source of selective pressure on these organisms, and guides development of
what should be termed “colonization factors” rather than “virulence factors.”
These factors, including capsule, IgA protease and pore-forming toxins, can be
expressed by commensal bacteria that are rarely pathogenic, such as
Streptococcus mitis (96). Further study is required to understand which
combination of virulence activities separates the potentially pathogenic from the
non-pathogenic colonizers. Accomplishing this aim would require a better
understanding of host mechanisms of discriminating between pathogenic and
non-pathogenic bacteria. Future work should also focus on testing the
relationship between virulence or colonization factors and transmission, the
conserved endpoint of carriage. The key to understanding invasive disease from
these opportunistic pathogens lies in examining colonization.
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DISSERTATION AIMS

Constantly exposed to environmental and microbial insults, the respiratory tract
is an important barrier mucosal surface that prevents systemic infection. Part of
this barrier protection is the innate inflammatory response, though inflammation
in the airway must be carefully regulated to preserve this vital organ’s gasexchange function (176). Despite this need to minimize airway inflammation,
contact from a wide range of microbes is rapidly countered by a mucosal
inflammatory response. Some bacteria, such as Streptococcus pneumoniae (the
pneumococcus) can evade this early inflammatory response, and even promote it
by expressing a pore-forming toxin, (94, 246) raising the question of whether
pneumococci have evolved to exploit host inflammation. We hypothesized
that inflammation in the upper respiratory tract promotes
pneumococcal colonization, persistence and transmission. To address
this overarching hypothesis, we pursued the following specific aims:

Aim 1: Determining whether the host response to influenza promotes
pneumococcal growth via sialylated mucin secretion. Airway responses
to influenza infection include secretion of mucins that are heavily decorated with
sialic acid residues, sugars that pneumococci can exploit as a nutrient source in
vitro. We determined that influenza infection of mice led to increased
transcription and secretion of the major airway mucin Muc5ac, which was
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accompanied by increased total and free sialic acid availability in the upper
respiratory tract. We used a mouse model of coinfection and found that influenza
promotes pneumococcal colonization. A novel flow cytometric assay
demonstrated this effect was specific to pneumococcal replication, in a manner
dependent on bacterial use of sialic acid and on host presence of Muc5ac.

Aim 2: Determining whether altered CCL2 signaling in infancy delays
clearance of pneumococcal colonization. Human infants carry
pneumococci more frequently than adults, and for longer periods. We adapted a
mouse model of pneumococcal colonization to examine whether infant mice
similarly exhibited delayed clearance of carriage. We studied transcriptional
responses in naive and colonized adult and infant mice and found the monocyteattracting chemokine CCL2 was tonically expressed at high levels in the infant
nasopharynx. We used flow cytometry to examine the cellular inflammatory
response to colonization and found delayed recruitment in infants of
macrophages necessary for clearing pneumococcal colonization. Restoring
macrophage recruitment with ectopic overexpression of CCL2 accelerated
pneumococcal clearance. Similar effects were seen with antibiotic treatment to
deplete the microbiota, rescuing the tonic CCL2 expression and macrophage
recruitment defect seen in infants.
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Aim 3: Determining whether host sensing of influenza infection in
infants promotes pneumococcal transmission. We adapted an infant
mouse model of pneumococcal transmission that depends on influenza
coinfection. We used this model to examine the host factors that influence
pneumococcal transmission, and found that host expression of the pattern
recognition receptor TLR2 limited transmission by affecting viral load. We
further examined the host responses at the cellular and transcriptional levels to
influenza and influenza-pneumococcal coinfection, and studied how they were
altered in the absence of TLR2.

Together, these specific aims examined how the innate inflammatory responses
to influenza infection (Aims 1 and 3) and during infancy (Aims 2 and 3) promote
pneumococcal colonization of the respiratory tract.
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Abstract

Much of the mortality attributed to influenza virus is due to secondary bacterial
pneumonia, particularly from Streptococcus pneumoniae. However, mechanisms
underlying this co-infection are incompletely understood. We find that prior
influenza infection enhances pneumococcal colonization of the murine
nasopharynx, which in-turn promotes bacterial spread to the lungs. Influenza
accelerates bacterial replication in vivo, and sialic acid, a major component of
airway glycoconjugates, is identified as the host-derived metabolite that
stimulates pneumococcal proliferation. Influenza infection increases sialic acid
and sialylated mucin availability, and enhances desialylation of host
glycoconjugates. Pneumococcal genes for sialic acid catabolism are required for
influenza to promote bacterial growth. Decreasing sialic acid availability in vivo
by genetic deletion of the major airway mucin Muc5ac or mucolytic treatment
limits influenza-induced pneumococcal replication. Our findings suggest that
higher rates of disease during co-infection could stem from influenza-provided
sialic acid, which increases pneumococcal proliferation, colonization and
aspiration.

Highlights:
-Influenza increases pneumococcal colonization, replication and aspiration
-Pneumococcal growth in co-infection depends on influenza-provided sialic acid
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-Sialylated airway mucin Muc5ac is required for influenza-mediated
pneumococcal growth
-Viral and bacterial neuraminidases release sialic acid from host cells in vivo

Introduction

Even before the discovery of its viral cause, bacterial infections have been
recognized as an important complication of influenza (138). Much of the
mortality attributed to this virus during both seasonal and pandemic influenza
seasons is actually from secondary bacterial pneumonia, particularly due to
Streptococcus pneumoniae, the pneumococcus (138).
All pneumococcal disease begins with asymptomatic colonization of the
nasopharynx (19). Though carriage is the prerequisite to invasive disease,
including pneumonia, most studies of influenza-pneumococcal interaction have
relied on directly inoculating bacteria into the lung, bypassing this first,
conserved step in pathogenesis (138, 148). However, there is evidence that
influenza predisposes the host to acquiring pneumococcal colonization (66).
Pneumococcal colonization in adults and children is temporally associated with
viral upper respiratory tract (URT) infections, including influenza, (99, 251) and
experimental influenza infection leads to higher pneumococcal loads in the
human nasopharynx (252). Additionally, the URT is the initial site of replication
for both pneumococci and influenza, (19, 133).
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In addition to focusing on the lower respiratory tract, studies of the interactions
between influenza and pneumococci have historically emphasized influenzainduced epithelial damage that alters lung architecture and promotes bacterial
adherence (148, 169). More recent studies have observed in vitro that influenza
neuraminidase can expose receptors for bacterial adherence by removing
terminal sialic acid residues from host glycoconjugates and in vivo that
neuraminidase inhibitors protect from post-influenza pneumonia (137, 177).
However, viral strains that do not cause pathologic changes in the epithelium can
still lead to secondary bacterial pneumonia in animal models, implying that
tissue damage is not necessary for influenza to promote bacterial disease (148).

Other work has focused on defects in anti-bacterial immunity directed by prior
viral infection. Influenza influences the immune response to secondary bacterial
challenge in murine models of co-infection (138, 148). Different groups have
demonstrated changes in neutrophil recruitment to the lungs, alveolar
macrophage function and macrophage recruitment to the nasopharynx during
post-influenza challenge (156, 209, 229). These immune effects are general, but
only a small subset of opportunistic bacterial pathogens cause the vast majority
of post-influenza pneumonia, and chief among these is the pneumococcus (106,
138, 148). The predominance of pneumococci in post-influenza disease suggests
that this bacterium is particularly able to take advantage of the influenza-infected
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environment. We hypothesized that influenza infection predisposes the host to
rapid pneumococcal growth in the nasopharynx by providing a nutrient source
for replicating bacteria.

Here, we show influenza promotes pneumococcal proliferation during
colonization in a mouse model of co-infection, that this rapid bacterial growth is
dependent on acquisition of the host metabolite sialic acid, that sialylated airway
mucins are required for this effect, and that both influenza and pneumococcal
neuraminidases contribute to the release of sialic acid from host substrates in
vivo.

Results

Influenza promotes pneumococcal colonization, growth and
aspiration
To determine whether influenza infection could promote bacterial colonization of
the URT, mice were intranasally inoculated with influenza A virus or PBS (mock).
This procedure was carried out using a small volume in unanesthetized mice to
avoid direct introduction into the lower respiratory tract. The x31 influenza strain
replicated efficiently in the URT, as measured by qRT-PCR viral titers in nasal
lavages, which peaked at 3 days post-inoculation (Fig. 1A). This infection did not
cause weight loss or other signs of systemic disease (Fig. 1B). Seven days after
40

inoculation, we challenged the mice with pneumococci 24 hrs before obtaining
nasal lavages to measure bacterial colonization density. Influenza infection
promoted >25-fold higher density of colonizing pneumococci with clinical
isolates of 2 different serotypes, 23F (strain P1121) and 4 (strain TIGR4) (Fig. 1C).

To address whether this difference in colonization density was due to influenza
promoting increased retention of the bacterial inoculum, we challenged mockand influenza-infected mice for <1 hr before measuring bacterial density in nasal
lavages. In contrast to observations at 24 hrs post-inoculation, there was no
difference in bacterial load 1 hr post-challenge, suggesting that initial adherence
to the epithelium was not responsible for the effect of prior influenza infection on
colonization (Fig. 1D).

We next tested whether influenza promoted bacterial growth, rather than or in
addition to inhibiting antibacterial immunity in the nasopharynx. To specifically
measure bacterial replication in vivo, we developed a flow cytometric assay using
carboxyfluorescein diacetate succinimidyl ester (CFSE), a dye used to track
eukaryotic cell division. Each round of cell division yields bacteria with less CFSE
fluorescence, which we measured in individual cells using flow cytometry (173).
We validated the assay in vitro and in vivo to demonstrate that only dividing
bacteria progressively lost CFSE fluorescence (Fig. S1). This assay was applied to
influenza co-infection by inoculating CFSE-labeled pneumococci into mice that
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had been previously influenza- or mock-infected. Eight hrs later, we recovered
the colonizing pneumococci in nasal lavages, stained the lavage with capsule
type-specific antibody to distinguish pneumococci from other particles, and
measured CFSE fluorescence per cell. Pneumococci colonizing mice that had
been previously infected with influenza had substantially less CFSE fluorescence
per cell than did those colonizing mock-treated mice (Fig. 1E). We measured the
median fluorescence intensity (MFI) of CFSE per bacterium in each condition to
quantify this growth effect. As replication occurred, the MFI decreased, and 1/
MFI increased (Fig. 1F). Additionally, we calculated the division index, the
number of divisions per cell (199). Bacteria colonizing influenza-infected mice
underwent more divisions than those in mock-infected mice (Fig. 1F). Over 8 hrs,
influenza promoted 3.7-fold more divisions per bacterial cell compared to PBS
treatment, an effect predicted to increase bacterial numbers by 13-fold (2^3.7).
This corresponded to the 12.1-fold increase in colonization density actually
observed, a further validation for this assay and demonstrating the importance of
bacterial growth in mediating increased colonization during co-infection.

Pneumonia generally begins with aspiration of upper airway contents into the
lungs, and clinical studies have noted that pneumococcal pneumonia is
associated with higher density of concurrent colonizing pneumococci in the
nasopharynx (5, 251). We hypothesized that the increased bacterial growth
stimulated by influenza could increase the likelihood of aspiration of
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pneumococci into the lungs. To test this possibility, we measured bacterial loads
in the bronchoalveolar lavage fluid (BAL) of mock- and influenza-treated mice 24
hrs after establishing pneumococcal colonization of the URT. Influenza-infected
mice had a higher bacterial burden in the lower respiratory tract compared to
mock-treated mice (Fig. 1G). Colonization density in the URT correlated with
bacterial load in the BAL (Spearman correlation coefficient, r = 0.6, P < 0.05).

Influenza increases sialic acid availability in the nasopharynx
We next sought to determine the nutrient(s) influenza was providing to
colonizing pneumococci. Pneumococci have complex growth requirements, and
can catabolize >30 different carbohydrates as carbon sources (28). To assess the
availability of possible nutrient sources from inflammation and epithelial damage
following influenza infection, we measured the total protein concentration of
nasal lavages obtained from mice 7 days after influenza or mock infection and
found no significant difference between these mice (Fig. 2A). We measured the
total reducing sugar content of nasal lavages using a tetrazolium assay and found
no significant difference between mock- and influenza-infected mice (Fig. 2B).
The tetrazolium assay can only measure reducing sugar, however (90). Sialic acid
is a non-reducing sugar that is the most common terminal, and therefore
accessible, modification on glycoconjugates in the airway (7). It is released from
cells and mucus after cleavage by influenza neuraminidase during viral
replication (177). Additionally, pneumococci express 2 to 3 neuraminidases per
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strain that liberate sialic acid (31). Sialic acid can support pneumococcal growth
in vitro as a sole carbon source, and pneumococci express a sialic acid
transporter, SatABC, required for its utilization (130).

The amount of sialic acid freely accessible in lavage fluid was below the limit of
detection in mock-infected mice but detectable in all mice infected with influenza
for 7 days (Fig. 2C). To account for the total sialic acid available in lavage fluid,
samples were treated with exogenous neuraminidase (data not shown) or mild
acid hydrolysis to release all bound sialic acid from glycoconjugates (157).
Influenza infection was associated with significantly more total sialic acid in the
nasopharynx compared to mock infection (Fig. 2D), as measured by the
thiobarbituric acid assay and validated by DMB-HPLC detection (Fig. S2).

Pneumococci exploit host glycoconjugates for growth during coinfection
After observing that influenza infection induced a selective increase in sialic acid
levels, we tested whether this increase was responsible for the increased
pneumococcal growth mediated by influenza. We inoculated mock- and
influenza-infected mice with pneumococci that could not catabolize sialic acid
("satABC or "nanA"nanB"satABC). The latter mutant also lacks all
neuraminidases present in the parental strain, preventing release of sialic acid
and thereby limiting access to additional sugars that underlie sialic acid on host
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glycoconjugates (31). The locus containing these 5 genes is shown in Fig. 3A (11).
After 8 hrs, we measured bacterial colonization. Neither mutant strain had a
defect in early colonization of mice in the absence of influenza. In contrast,
pneumococci unable to metabolize sialic acid no longer exhibited increased
colonization in the presence of influenza (Fig. 3B).

Next, we applied the CFSE assay to measure bacterial growth, and determined
that the number of divisions per cell was lower with both sialic acid mutant
strains compared to WT in the presence, but not absence, of influenza (Fig. 3C).
Genetic correction of the mutation in sialic acid utilization ("satABC/satABC+)
restored increased bacterial load in the presence of influenza to WT levels (Fig.
3D). To test whether influenza could promote the outgrowth of sialic acidcatabolizing bacteria, mock- and influenza-infected mice were challenged with a
mixed inoculum of sialic acid-catabolizing and "satABC mutant pneumococci.
One day later, the proportion of sialic-acid catabolizing bacteria colonizing the
nasopharynx had increased 10-fold in the presence of influenza (Fig. 3E).

Sialylated airway mucins are required for influenza-induced
pneumococcal growth
Since pneumococci can grow on mucin glycoproteins as a sole carbon source in
vitro, (269) we assessed the availability of mucus, as seen by alcian blue staining
for acidic mucopolysaccharides, in the URT. Influenza increased the amount of
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mucus present in the nasopharyngeal lumen (Fig. 4A). We next examined
expression of Muc5ac, the major airway mucin secreted during inflammation and
one that is highly decorated by sialic acid residues, (107, 202). Influenza induced
secretion of Muc5ac onto the mucosal surface during influenza infection (Fig.
4B). This was accompanied by increased Muc5ac transcription in the URT that
was maximal at 7 dpi (Fig. 4C). These results correlated with the availability of
total sialic acid, which was also maximal at 7 dpi (Fig. 2D). To test whether
mucins were a major source of sialic acid during influenza infection, we first
examined Muc5ac-/- mice. There was no defect in pneumococcal colonization or
growth in Muc5ac-/- mice in the absence of influenza, but the influenza-mediated
increases in bacterial load (Fig. 4D) and replication (Fig. 4E) were attenuated in
mice that lack this airway mucin. These decreases in growth and bacterial density
in Muc5ac-/- mice were not due to a less robust influenza infection, as determined
by viral titers (data not shown). To further assess the role of mucins in
pneumococcal replication during co-infection, we intranasally treated mock- and
influenza-infected WT mice with the mucolytic agent N-acetylcysteine daily until
pneumococcal challenge. Mucolytic treatment reduced bacterial load (Fig. 4F)
and growth (Fig. 4G), but only in influenza-infected mice. Both genetic deletion
and mucolytic treatment reduced total sialic acid in the influenza-infected
nasopharynx, confirming that sialylated mucins are a host-derived source of sialic
acid pneumococci exploit during co-infection (Fig. 4H).
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Influenza and bacterial neuraminidases desialylate host substrates
We next examined whether viral and bacterial neuraminidases released sialic
acid from host sources for pneumococci to use for growth. We qualitatively
measured sialic acid release from the epithelial surface by fluorescence
microscopy using a fluorescently-labeled lectin from Erythrina cristagalli, which
binds to galactose residues that are exposed when sialic acid is cleaved (35). After
7 days of influenza or mock infection, URT sections from mouse heads were
stained with the E. cristagalli lectin. Influenza infection promoted increased
desialylation of the mucosal surface in the nasopharynx. Bacterial neuraminidase
desialylated host cells further, as there was additional lectin binding in samples
from mice given pneumococci for 24 hrs after 7 days of influenza. This effect was
specific to the pneumococcal neuraminidases, as the epithelial surface in
influenza-infected mice colonized with neuraminidase-deficient ("nanA"nanB)
pneumococci had less lectin binding, and therefore less desialylation, than did
those colonized with WT pneumococci (Fig. 5A). As a quantitative measure of
desialylation, we used flow cytometry to quantify desialylation on infiltrating
leukocytes (>80% neutrophils), which are abundant in the influenza-infected
airway and can be easily obtained by nasal lavage (data not shown). This method
confirmed the pattern of desialylation observed with fluorescence microscopy
(Fig. 5B). These findings indicated that both viral and bacterial neuraminidases
contribute to the desialylation in vivo of host substrates during co-infection.
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Sialic acid catabolism contributes to pneumococcal colonization in
the absence of influenza
To assess the role of sialic acid catabolism during pneumococcal colonization, we
measured sialic acid in nasal lavages from mice inoculated with pneumococci in
the absence of influenza infection. Total sialic acid increased over the duration of
colonization, though no free sialic acid was detectable (Fig. 6A). Consistent with
the slow increase in sialic acid during colonization, we observed that WT
pneumococci outcompeted "satABC, and that this outcompetition increased over
time, but was delayed compared to influenza co-infection (Fig. 6B). As with
influenza infection, pneumococcal colonization induced URT transcription of the
sialylated mucin Muc5ac (Fig. 6C).

Nutrient-poor conditions on the human mucosal surface favor growth
of sialic acid catabolizing pneumococci
To extend our findings on sialic acid catabolism to human samples, we competed
bacterial strains for growth in vitro in human nasal airway surface fluid (hNASF),
the natural environment in which pneumococci replicate. There was little
competition between WT and "satABC pneumococci when grown in nutrient
broth that contains glucose, (Fig. 7A) an in vitro preferred carbon source not
found in airway secretions (182). This competitive advantage due to sialic acid
catabolism increased 15-fold when pneumococci were grown in nutrient-limited
hNASF. In contrast, there was no significant advantage for WT over the
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genetically corrected "satABC/satABC+ strain in growth in hNASF (Fig. 7A).
This effect correlated with the higher levels of sialic acid found in hNASF
compared to nutrient broth (Fig. 7B). These sialic acid levels could not be directly
compared to those found in murine nasal lavages, as the latter are dilutions of the
epithelial lining fluid. The total volume of upper airway surface fluid in an adult
mouse has been estimated as 3 µL (10). Assuming the 200 µL nasal lavage
contained the entire surface lining fluid, the lavages are at least a 1:67 dilution of
that fluid. The ~30 µM sialic acid concentration measured, therefore, would
correspond to >2 mM sialic acid on the mucosal surface during co-infection, a
concentration sufficient to promote growth in vitro as a sole carbon source (Fig.
7C).

Discussion

Influenza has long been associated with secondary bacterial pneumonia, but how
this viral infection primes the host for the rapid development of high bacterial
loads has not been fully understood. Here, we demonstrated that influenza
infection predisposed mice to increased pneumococcal colonization in the
nasopharynx, and that faster bacterial replication contributed to this effect. This
influenza-mediated growth led to increased aspiration into the lower respiratory
tract, and was dependent on pneumococcal catabolism of the host sugar sialic
acid and host expression of sialylated airway mucins, with both viral and
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bacterial neuraminidases contributing to the desialylation of host cells in vivo.
Sialic acid utilization was important even during pneumococcal colonization in
the absence of influenza, but to a lesser extent, consistent with the lower levels of
sialic acid present without influenza infection.

In this study, we challenged mice with pneumococci after 7 days of influenza
infection in the URT. At 7 days postinfection, influenza viral titers are declining
from a peak reached at 3 to 5 dpi, the same time at which sialic acid levels and
sialylated mucin expression in the nasopharynx are increasing. Previous animal
studies have indicated this timepoint correlates with the peak of susceptibility to
pneumonia when pneumococci are introduced directly into the lower respiratory
tract (143, 229). The window of susceptibility to pneumococcal pneumonia is also
7 to 10 days following influenza infection in humans (218).

Correlations between URT pneumococcal colonization density and pneumonia
have been observed in human patients, but it has not been clear whether higher
bacterial burdens in the upper airway precede pneumonia or are an effect of
lower airway disease(5). We found that influenza, by promoting higher bacterial
load in the nasopharynx, led to increased aspiration of pneumococci into the
lower respiratory tract, experimentally demonstrating that higher levels of
colonization can increase a key step in the early pathogenesis of pneumonia.
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Previous studies of the interaction between influenza and pneumococci have
focused on epithelial damage or immune dysfunction induced by the viral
infection, promoting increased bacterial adherence or decreased bacterial
clearance, respectively (138, 148). We found no difference in initial adherence of
the bacterial inoculum after influenza infection, and further found no increases in
total protein or glycan content, suggesting this infection did not cause extensive
tissue damage. Using the dilution of CFSE dye, we demonstrated a role for
bacterial replication in mediating increased colonization due to influenza.
Previous studies of the interaction between influenza and bacteria have measured
bacterial numbers, the sum of bacterial growth and clearance. We measured both
bacterial numbers and bacterial growth, allowing us to separate the contribution
of bacterial growth from that of immune evasion. Our data are consistent with
previous studies demonstrating the importance of viral neuraminidase for the
interaction of influenza and pneumococci (177, 178). Those studies emphasized
neuraminidase removing sialic acid to expose underlying receptors for
pneumococci, but the same enzymatic activity would also release free sialic acid
into the nasopharynx for pneumococci to utilize.

Our work has implications for the therapeutic use of neuraminidase inhibitors.
Most clinical studies of neuraminidase inhibitor efficacy have focused on early
treatment, (76, 82) but experiments in mice demonstrated survival benefits to
neuraminidase inhibitor treatment during co-infection even at later timepoints
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when there was no effect on viral replication (137). Our results may provide a
mechanistic understanding of this effect, as inhibiting viral neuraminidase may
limit sialic acid release even after the peak in viral replication. Additional studies
on the effect of late neuraminidase inhibitor treatment on complications related
to bacterial density, such as pneumonia, could be warranted. Bacterial
neuraminidases, including pneumococcal NanA and NanB, are not inhibited by
clinically-used neuraminidase inhibitors at concentrations reached in vivo (165).
Broader neuraminidase inhibitors that can prevent bacterial acquisition of sialic
acid and underlying sugars may be an important, unexplored therapeutic
strategy.

We observed desialylation of the mucosal surface and leukocytes during influenza
infection, exacerbated by co-infection with neuraminidase-expressing
pneumococci. We found that transcription of Muc5ac was upregulated in the
nasopharynx during influenza infection as part of the inflammatory response,
consistent with a previous report in the lungs of influenza-infected mice (14). We
also found that mucus and Muc5ac secretion increased during influenza
infection, and that reducing mucins by genetic knockout of Muc5ac, or
solubilizing mucus by N-acetylcysteine treatment decreased influenza-induced
pneumococcal growth. Mucins are 50 to 90% glycan by mass and are heavily
sialylated, particularly at the terminal, most accessible ends of sugar chains (7,
202). The epithelial surface is also heavily sialylated, and could serve as an
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additional source of sialic acid during influenza infection (114). The commensal
flora of the nasopharynx could also provide sialic acid (211).

Sialic acid is both necessary and sufficient for pneumococcal colonization in mice
(130, 238). We noted a competitive disadvantage in vivo that increased over 7
days of colonization for pneumococci that lack the sialic acid transporter SatABC,
consistent with previous work showing a defect in colonization at 5 days
postinoculation (130). Increased nasal secretions, reflecting greater sialylated
mucin production, have been associated with higher density of pneumococcal
colonization in children (198). Exogenous sialic acid, but not other amino sugars,
has been shown to increase colonization density in the airway (238). In vitro,
sialic acid can promote pneumococcal growth as a sole carbon source (130). The
amount of nasopharyngeal sialic acid we measured during influenza infection is
likely to be an underestimate, as it does not include sialic acid still bound to
epithelial cells that would not be removed by nasal lavage. Sialic acid release by
viral and bacterial neuraminidases also exposes underlying sugars, such as
galactose and N-acetylglucosamine, that can be liberated by the sequential
activity of pneumococcal exoglycosidases to serve as additional carbon sources
(31, 101). This effect could explain why pneumococci that could not cleave or
catabolize sialic acid ("nanA"nanB"satABC) had a stronger defect in influenzamediated growth compared to those that could not catabolize sialic acid
("satABC). The viral neuraminidase could also complement mutations in the
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pneumococcal neuraminidases. Free sialic acid only accumulated enough to be
detected after 7 days of influenza infection, even though viral titers peaked
earlier. This timepoint, however, represented the peak of sialylated mucin
availability. Our results suggest that the combination of increased mucin
availability and neuraminidase activity is required for providing sufficient
amounts of sialic acid.

Obtaining a source of carbon is necessary for bacterial growth in any
environment, but how this occurs during colonization of the nutrient-poor
mucosal surface has been unclear (28). Free sugar is particularly limited in the
nasopharynx, the pneumococcal niche, unlike in the intestines or oral cavity
(182). In the gut, sialic acid released by the sialidase of one bacterial species can
promote sialic acid catabolism-dependent growth of another (161). Carbon
acquisition is especially important for the pneumococcus, which devotes more of
its genome to sugar transporters than any other sequenced bacterium (234). This
diversity implies that pneumococci may encounter different host sugars in
abundance in distinct microenvironments; infection with neuraminidaseexpressing viruses such as influenza could provide one such microenvironment.
Pneumococci are not the only bacteria that can use sialic acid. Interestingly, the
other prominent pathogens in secondary bacterial pneumonia following
influenza, Staphylococcus aureus and Haemophilus influenzae, can also
catabolize this host sugar (170, 248). Sialic acid utilization could also contribute
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to other common bacterial complications following influenza infection, such as
acute otitis media (138).

Experimental Procedures

Mice
6-8 week old C57Bl/6 mice were obtained from Jackson Laboratory. Muc5ac-/mice on a C57Bl/6 background were previously described (72). Procedures were
carried out according to an animal protocol approved by the University of
Pennsylvania IACUC.

Influenza infection
Mice were intranasally inoculated with 2 x 104 TCID50 of influenza A virus, strain
HKx31 (H3N2 from A/Hong Kong/1/1968 with the backbone of PR8 virus),
diluted into 10 µL PBS.

Bacterial strains and colonization
Pneumococcal strains included TIGR4 (234) and P1121, (135) clinical isolates of
capsule types 4 and 23F, respectively. Mutants of P1121 in the sialic acid
transporter (satABC) were previously made using the Janus cassette to create
unmarked and correct mutations (130). Mutants in the neuraminidase genes
nanA and nanB were constructed as described previously by introducing
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antibiotic resistance cassettes (100). Pneumococci were grown in tryptic soy (TS)
nutrient broth at 37º C until mid-log phase. For mouse colonization, 107 CFU
bacteria were inoculated intranasally in a volume of 10 µL. Mice were sacrificed,
and nasal lavages obtained with 200 µL PBS. Lavages were plated on TS agar
supplemented with catalase (5,000 U/plate) (Worthington Biochemical) and 5
µg/mL neomycin for quantitative culture in 5% CO2. TS agar was supplemented
with 200 µg/mL streptomycin to distinguish "satABC pneumococci from WT.
For bronchoalveolar lavage, 1 mL PBS was instilled into the lungs intratracheally,
withdrawn with a syringe, and used for quantitative culture.

CFSE staining
Bacteria were resuspended in 1 mL PBS with 1% catalase and 10 µM carboxyfluorescein diacetate succinimidyl diester (Molecular Probes). Reactions were
incubated at 37º C for 25 min, then washed 3 times in PBS. Mice were inoculated
with CFSE-labeled pneumococci. After 8 hrs, mice were sacrificed and nasal
lavages obtained, then prepared for flow cytometry.

Flow Cytometry
For the in vivo CFSE assay, nasal lavages were obtained from mice inoculated
with CFSE-labeled pneumococci. Samples were fixed and stained with typing
serum specific to the capsule-type used (Statens Serum Institut), followed by
AF647-labeled secondary antibody to rabbit IgG, then analyzed by flow
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cytometry. For measurement of desialylation, nasal lavages were stained with
FITC-labeled lectin from Erythrina cristagalli (Vector Labs), and antibodies to
identify neutrophils: anti-Ly6G (clone 1A8) and anti-CD11b. Flow cytometry was
conducted using FACS Calibur and FACS Canto instruments (Becton Dickinson),
and analyzed using FlowJo software (Tree Star).

Protein, reducing sugar and sialic acid measurements
Protein was measured by bicinchonic acid assay (Pierce). Reducing sugar was
measured by tetrazolium blue assay (90). Samples were diluted 1:100 in 0.1%
tetrazolium blue, 0.05 M NaOH and 0.5 M potassium sodium tartrate. Samples
were boiled for 10 min, and absorbance measured at 655 nm. Sialic acid was
measured by thiobarbituric acid assay (157, 223). To measure total sialic acid,
samples were first incubated with 0.1 N H2SO4 for 30 min at 80º C. All samples
were then incubated with 25 µM periodic acid/62.5 mM H2SO4 for 30 min at 37º
C, followed by boiling in 2% sodium arsenite/0.5 M HCl and 6% thiobarbituric
acid for 10 min. Absorbance was measured at 550 nm and compared to a
standard curve to calculate concentrations in lavage fluid. The specificity of this
assay was confirmed by using exogenous neuraminidase instead of acid
hydrolysis to enzymatically release sialic acid.

qRT-PCR
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RNA was harvested from the URT epithelium by lavage with RLT buffer (Qiagen)
with 1:100 !-mercaptoethanol. RNA was isolated with the RNeasy kit (Qiagen),
and cDNA reverse transcribed with the High-Capacity cDNA Reverse
Transcription kit (Applied Biosystems). Reactions were carried out with Sybr
Green reagents (Applied Biosystems), with 10 ng cDNA and 0.5 µM primers.
Comparisons were made between conditions by the ""CT method. Primer
sequences are in Supplemental Experimental Procedures.

Western blot
Proteins in nasal lavages were separated by SDS-PAGE on a 10% Tris gel (BioRad) and transferred onto PVDF membrane. Muc5ac was detected by polyclonal
antibody (Santa Cruz Biotechnology) and rabbit anti-goat secondary antibody
conjugated to alkaline phosphatase (Sigma).

Microscopy
Tissue sections of the URT were obtained as previously described (160). Staining
and microscopy was performed as described, modified by blocking in 1% gelatin
in PBS when using E. cristagalli lectin.

Growth in human nasal airway surface fluid
Human nasal airway surface fluid was isolated as previously described (64).
Pneumococci were grown to log-phase in TS nutrient broth and diluted to a
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concentration of 104 CFU/mL in both hNASF and TS. Reactions were
supplemented 1:100 with catalase and incubated at 37º C in 5% CO2 for 8 hrs.
Samples were plated for quantitative culture at the start and end of the growth
period, and colonies patched onto antibiotic selective media to calculate
competitive indices. Pneumococci were grown in chemically defined medium as
previously described, (104) with sialic acid in place of glucose.

Statistical analysis
Prism (Graphpad) was used for statistical analysis. Comparisons were made by
Mann-Whitney U-test for colonization (CFU) data, and by Student’s t-test for all
other data. For multiple comparisons, we used Kruskal-Wallis with Dunn’s
posttest or 1-way ANOVA with Newman-Keuls posttest, respectively.
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Figure Legends

Figure 1: Influenza promotes pneumococcal colonization, growth and
aspiration
(A) Mice were infected with influenza for the indicated number of days, nasal
lavages with RLT RNA lysis buffer obtained, and qRT-PCR performed to measure
the relative expression of x31 viral nucleoprotein (NP). (B) Mice given PBS
(mock, open symbols) or influenza (closed symbols) were weighed daily for 7
days, and the percent change in weight from baseline graphed. (C) Mice were
infected with influenza or PBS, followed 7 days later by intranasal inoculation
with bacteria of the indicated serotype. After 24 hrs post-bacterial inoculation
(hpi), nasal lavages were obtained and plated for quantitative culture of
colonizing pneumococci. (D) Mice were inoculated with influenza or PBS,
followed 7 days later by challenge with strain P1121. Within 1 hr, nasal lavages
were obtained and plated for quantitative culture (CFUs). (E) After 7 days of
mock (black line) or influenza (grey shaded) infection, mice were inoculated with
CFSE-labeled pneumococci for 8 hrs. Nasal lavages were obtained, fixed and
stained for pneumococcal capsule, and flow cytometry performed to compare
bacterial replication. (F) The median fluorescence intensity (MFI) of CFSE per
bacterial cell was calculated for each condition, and displayed as 1/MFI, or
number of divisions per cell (division index). (G) Mock or influenza-infected mice
were challenged 7 days later with WT pneumococci for 24 hrs. Bronchoalveolar
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lavages were obtained and plated for quantitative culture. Horizontal lines
indicate median values, and data in F are represented as mean +/- SD. n.s. = not
significant, * = p < 0.05, ** = p < 0.01, *** = p < 0.001. All experiments were
performed at least twice, with 4-11 mice per group.

Figure 2: Influenza increases sialic acid availability in the
nasopharynx
(A-D) Mice were intranasally inoculated with influenza (closed bars) or mock
(PBS, open bars) for 7 days, then nasal lavages obtained to measure levels of
protein (A), reducing sugars (B) and sialic acid (C, D) in the lavages. Sialic acid
measurements were performed without (C) or with (D) mild acid hydrolysis to
measure free and total sialic acid, respectively, in lavages from mice infected with
influenza for the indicated number of days (dpi). Data are represented as mean
+/- SD. ND = not detected (below the limit of detection, indicated with a dotted
line). n.s. = not significant, ** = p < 0.01. Experiments were performed at least
twice, with 3-14 mice per group.

Figure 3: Pneumococci exploit host glycoconjugates for growth during
co-infection
(A) The genetic locus in strain P1121 containing the neuraminidase (nanA, nanB)
and sialic acid transport (satABC) genes is displayed. (B) Seven days after mock
(open symbols) or influenza infection (closed symbols), mice were inoculated
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with CFSE-labeled pneumococci of the indicated genotypes for 8 hrs. Nasal
lavages were obtained and plated for quantitative culture. (C) Lavages were fixed,
stained for pneumococcal capsule, and flow cytometry performed to measure
bacterial replication (division index). (D) Mice were infected with influenza for 7
days, followed by 24 hrs of colonization with the indicated bacterial strains. Nasal
lavages were plated for quantitative culture. (E) Seven days after mock or
influenza infection, mice were given a mixed inoculum of sialic acid-catabolizing
and "satABC pneumococci. One day later, nasal lavages were obtained and
plated for quantitative culture. Colonies from the plated inoculum and the
lavages were patched onto antibiotic-containing media to determine the relative
advantage in vivo of sialic acid catabolism and calculate competitive indices. CI >
1 indicates outcompetition of the streptomycin-resistant "satABC pneumococci,
and was defined as the ratio of WT/mutant bacteria in the output (nasal lavage),
divided by the ratio of WT/mutant bacteria in the input (inoculum). Data in C are
represented as mean +/- SD. Horizontal lines indicate median values. n.s. = not
significant, * = p < 0.05, ** = p < 0.01, *** = p < 0.001. Experiments were
performed at least twice, with 3-15 mice per group.

Figure 4: Sialylated airway mucins are required for influenza-induced
pneumococcal growth
(A) Mouse heads were obtained after 7 days of mock or influenza infection, fixed,
decalcified and sectioned. URT sections were stained with alcian blue and nuclear
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fast red. Scale bars, 50 µm. (B) Nasal lavages were obtained from mice infected
with influenza or PBS for 7 days, then analyzed by Western blot for the presence
of Muc5ac. (C) Nasal lavages with RLT RNA lysis buffer were obtained from mice
influenza or mock-infected for 7 days. qRT-PCR was performed, and relative
expression of Muc5ac measured. (D) Mice of indicated genotype were mock or
influenza infected for 7 days, followed by inoculation with CFSE-labeled
pneumococci for 8 hrs. Nasal lavages were obtained and plated for quantitative
culture. (E) Lavages were also fixed, stained for pneumococcal capsule, and flow
cytometry performed to measure bacterial replication (division index). (F-G)
Wildtype mice were infected with influenza or mock, followed by daily treatment
for 7 days with vehicle (PBS) or 0.5 M N-acetylcysteine (NAc). CFSE-labeled
pneumococci were inoculated for 8 hrs, then nasal lavages obtained and used for
quantitative culture (F) and flow cytometric analysis of cell division (G). (H) Total
sialic acid content was measured by thiobarbituric acid assay on samples from DG. Data are represented as mean +/- SD. Horizontal lines indicate median values.
* = p < 0.05, ** = p < 0.01. Experiments were performed at least twice, with 3-13
mice per group.

Figure 5: Influenza and bacterial neuraminidases desialylate host
substrates
(A-B) Mouse heads (A) and nasal lavages (B) were obtained from separate mice
after 7 days of influenza or mock infection, followed by 24 hrs of colonization
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with WT or "nanA"nanB pneumococci, or PBS. Heads were fixed, decalcified
and sectioned. URT sections were stained with DAPI and FITC-labeled lectin
from E. cristagalli that binds galactose residues exposed when sialic acid is
removed. All images were taken with the same optical settings. Scale bars, 50 µm.
Lavages were stained with FITC-labeled E. cristagalli lectin. Flow cytometry was
performed by gating on neutrophils and comparing desialylation. Experiments
were performed at least twice, with 3-10 mice per group.

Figure 6: Sialic acid catabolism contributes to pneumococcal
colonization in the absence of influenza
(A) Mice were colonized with pneumococci for the indicated number of days.
Sialic acid concentrations in lavages were measured by thiobarbituric acid assay,
with or without acid hydrolysis to measure total (solid bars) and free sialic acid
(open bars), respectively. (B) WT and "satABC pneumococci were competed in
vivo by colonizing naive mice with mixed inocula. Nasal lavages were plated for
quantitative culture and colonies from the inocula and lavages patched onto
antibiotic-selective media to determine the relative advantage of sialic acid
catabolism in vivo and calculate competitive indices. CI > 1 indicates WT
outcompeted "satABC pneumococci. (C) Nasal lavages were obtained with RLT
RNA lysis buffer from mice colonized with pneumococci for the indicated number
of days. qRT-PCR was performed to measure relative expression of Muc5ac. Data
are represented as mean +/- SD. ND = not detected (below the limit of detection,
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indicated with a dotted line), * = p < 0.05. Experiments were performed at least
twice, with 3-20 mice per group.

Figure 7: Nutrient-poor conditions on the human mucosal surface
favor growth of sialic acid catabolizing pneumococci
(A) Bacteria of the indicated genotypes were grown for 8 hrs in mixed inocula in
tryptic soy nutrient broth, or in nutrient-limited human nasal airway surface fluid
(hNASF). Aliquots were plated at the beginning and end of the growth period,
and colonies patched onto antibiotic-selective media to determine the relative
advantage of sialic acid catabolism in vivo and calculate competitive indices. CI >
1 indicates WT outcompeted the indicated mutant strain. (B) Total sialic acid in
the growth media used in A was measured by thiobarbituric acid assay after acid
hydrolysis. (C) WT (solid bars) and "satABC (open bars) pneumococci were
grown for 24 hrs in chemically defined medium with the indicated concentrations
of sialic acid as the sole carbon source. Data show fold-growth compared to
inoculum. Data are represented as mean +/- SD. n.s. = not significant, * = p <
0.05, ** = p < 0.01, *** = p < 0.001. Experiments were performed at least twice.
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Figure S1: Bacterial replication can be measured in vitro and in vivo
using CFSE, related to Figure 1

(A) CFSE-labeled pneumococci were grown in vitro in TS or PBS for 4 hrs. Flow
cytometry was performed to measure the amount of CFSE fluorescence, and
therefore the amount of replication, per cell. (B) CFSE-labeled pneumococci were
incubated for 4 hrs in TS or TS containing bacteriostatic concentrations of the
antibiotic novobiocin. (C) Mice were intranasally inoculated with CFSE-labeled
pneumococci, and nasal lavages obtained 1 and 16 hrs later. Flow cytometry was
performed to measure CFSE per cell at each timepoint. (D) Pneumococci were
CFSE-labeled and then heat-killed (HK) to prevent subsequent growth. These
heat-killed bacteria were inoculated into mice for 16 hrs, then nasal lavages
obtained. Flow cytometry was performed and compared to the CFSE fluorescence
of the heat-killed inoculum. (E) Viable CFSE-labeled pneumococci were
inoculated into mice for 4 hrs, then nasal lavages obtained. Lavages were stained
with propidium iodide and flow cytometry performed to compare CFSE
fluorescence between all cells and live cells only.
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Figure S2: Validation of sialic acid measurements, related to Figure 2
(A) A subset of mock- and influenza-infected samples were analyzed for sialic
acid content by DMB-derivatization and reverse-phase HPLC. (B) The same
samples were analyzed by both thiobarbituric acid assay (y-axis) and DMB-HPLC
(x-axis), and results from each method compared by linear regression. Nasal
lavages from 3 mice were pooled into each sample analyzed, for a total of 6 mice
per condition. Data are represented as mean +/- SD. * = p < 0.05

Supplemental Experimental Procedures:

CFSE Staining for Controls
CFSE-labeled pneumococci were incubated in TS or PBS (as a no-growth control)
for 4 hrs, then fixed and stained for flow cytometry as described in Experimental
Procedures. CFSE-labeled pneumococci were also incubated for 4 hrs in TS or TS
containing bacteriostatic concentrations of the antibiotic novobiocin, a gyrase
inhibitor that does not interfere with protein synthesis. To confirm the specificity
in vivo of the CFSE assay for growing bacteria, pneumococci were CFSE-labeled
and then heat-killed (HK) to prevent subsequent growth. The inoculum was
plated to confirm no viable bacteria remained. These heat-killed bacteria were
inoculated into mice for 16 hrs, then nasal lavages obtained. To verify that
bacteria that appeared to be growing based on CFSE dilution were viable, CFSElabeled pneumococci were inoculated into mice for 4 hrs, then nasal lavages
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obtained. Lavages were not fixed, but were stained with propidium iodide and
capsule type-specific antibody. Flow cytometry was performed, and the CFSE
fluorescence per cell was compared between all cells and live cells only.

Sialic acid measurements
To validate the thiobarbituric acid assay, a subset of samples were also analyzed
by DMB-derivatization and reverse-phase HPLC at the UCSD Glycotechnology
Core. Briefly, free sialic acid was measured on half of each sample using a 10,000
MWCO spin filter. The other half of each sample was left unfiltered to measure
total sialic acid. Each aliquot was hydrolyzed in 2 N acetic acid for 3 hrs at 80˚ C,
followed by filtration through a 10,000 MWCO spin filter to remove protein.
Samples were dried in a centrifugal evaporator and derivatized with DMB for 2.5
hrs at 55˚ C, followed by injection onto a Waters Acquity UPLC System. A Waters
BEH C18 column (2.1 x 100 mm, 1.8µm particle size) was used, with a gradient of
7% Aqueous Methanol (Solvent A) and 7% Methanol in Acetonitrile (Solvent B)
and initial conditions of 95%A and 5%B. The total run time was 14.5 min and the
sialylated species were eluted from the column within the first 5 min. The
amount of each sialic acid was determined by referencing to standards of known
amounts.
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qRT-PCR Primers
GAPDH-F 5’-AGG-TCG-GTG-TGA-ACG-GAT-TTG-3’; GAPDH-R 5’-TGT-AGACCA-TGT-AGT-TGA-GGT-CA-3’; Muc5ac-F 5’-CCA-TGC-AGA-GTC-CTC-AGAACA-A-3’; Muc5ac-R 5’-TTA-CTG-GAA-AGG-CCC-AAG-CA-3’; (17) x31 NP-F 5’CAG-CCT-AAT-CAG-ACC-AAA-TG-3’; x31 NP-R 5’-TAC-CTG-CTT-CTC-AGTTCA-AG-3’ (75).

81

CHAPTER 3:
Clearance of pneumococcal colonization is delayed
in infant mice due to altered CCL2 regulation
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Abstract
Streptococcus pneumoniae is a significant cause of morbidity and mortality,
especially in children. Colonization is the prerequisite to invasive pneumococcal
disease, and is particularly common and prolonged in children. We studied
prolonged carriage using a mouse model of pneumococcal colonization by
intranasally inoculating infant (7-day old) and adult (6-8 week old) mice. Adult
mice had completely cleared colonization by 21 days postinoculation (dpi), while
mice colonized as infants still carried pneumococci by 45 dpi. We used this model
to examine the mechanisms underlying delayed pneumococcal clearance in
infants. Macrophages, the effector cells in clearing pneumococci from adults,
exhibited delayed recruitment into the nasopharyngeal lumen of infant mice.
Inflammation was not completely impaired in infant mice, however, as they
appropriately recruited neutrophils into the nasopharynx during the acute phase
of colonization. This lack of macrophage recruitment was paralleled by a failure
to upregulate Ccl2 (Mcp-1), a macrophage chemoattractant that is required in
adult mice to promote clearance. Surprisingly, baseline levels of Ccl2 expression
were significantly higher in the infant upper respiratory tract compared to the
adult URT, and this effect required the presence of the infant microbiota.
Furthermore, infant mice expressed more CCL2 protein in serum than adult
mice, suggesting a systemic effect on expression of CCL2 in infants. Peritoneal
macrophages isolated from infant mice also expressed more Ccl2 than those
cultured from adults, additional evidence of a systemic effect on infant CCL2
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signaling. Taken together, these results demonstrate that CCL2 signaling is
altered at baseline in infant mice, which prevents the development of appropriate
innate cell infiltration in response to pneumococcal colonization, and is
associated with delayed clearance of pneumococcal carriage.

Introduction
Despite effective antibiotics and vaccines, Streptococcus pneumoniae (the
pneumococcus)remains a leading cause of infant mortality in the developing
world, resulting in more than 1 million deaths annually (166). Worldwide, this
gram-positive bacterium is a common cause of pneumonia at all ages. The
spectrum of pneumococcal disease ranges from local infections such as acute
otitis media (middle ear infection) and pneumonia, to invasive infections
including meningitis and sepsis. In all these diseases, the pathogenic
pneumococci initially disseminate from a single common site of colonization and
carriage, the nasopharynx (19, 65).

Disease, however, represents an evolutionary dead-end for the pneumococcus,
since transmission to a new host occurs only via respiratory secretions from the
reservoir of bacteria colonizing the nasopharynx (113, 262). Clinical studies and
experimental colonization in humans have revealed that different pneumococcal
serotypes can colonize repeatedly and concurrently. Each carriage event is
maintained for weeks to months before being cleared (65, 135, 225).
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Pneumococcal colonization is particularly common in young children, with a
peak prevalence of 55 percent in children 3 years old, declining to 8 percent of 10
year olds and an even smaller proportion of adults (19, 20). Carriage is not only
more frequent in children, but is also prolonged. Multiple studies across 3
continents demonstrate a consistent 2-fold increase in the duration of a given
pneumococcal colonization event in children compared to adults (45, 81, 240).
The mechanism for delayed pneumococcal clearance by infants is not clear,
however. One proposed explanation for more efficient clearance with increasing
age is the development of antipneumococcal antibodies following clearance of
pneumococcal carriage. These anticapsular antibodies cannot be the sole
mediator of acquired protection against pneumococci, however, as pneumococcal
disease decreases in childhood for all serotypes at the same rate, a finding that
would not be expected if each serotype would need to be carried and cleared to
generate type-specific anticapsular antibodies (118). This analysis implies that
non-serotype specific mechanisms are responsible for the faster clearance of
pneumococcal colonization that occurs with increasing age.

The molecular mechanisms underpinning pneumococcal clearance have been
studied in an adult mouse model that faithfully recapitulates multiple aspects of
human carriage, including the duration of carriage (94). Clearance of
colonization is independent of the acute inflammatory response and neutrophil
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influx into the nasopharynx, and furthermore does not require the development
of anticapsular antibodies (136, 246). Rather, clearance depends on the
recruitment of macrophages into the airway lumen, a process that requires Th17
cell development and the subsequent expression and sensing of the monocyte
chemoattractant CCL2 (MCP-1) (49, 121, 271). Chemokine production and
macrophage recruitment occur in response to sensing by pattern recognition
receptors TLR2 and Nod2, (49, 271) as well as the macrophage scavenger
receptor MARCO (54). How these pathways that normally lead to clearance of
colonization from an adult host are altered in infant mice is unclear.

Here, we show that infant mice are delayed in clearing pneumococcal
colonization, that this prolonged carriage is accompanied by slower macrophage
recruitment, that increased Ccl2 expression due to acquisition of the microbiota
is required for this delayed recruitment, and that infants have systemic
alterations in CCL2 signaling.

Results

Pneumococcal carriage is prolonged in infant mice
To determine whether pneumococcal carriage is prolonged in infant mice, adult
(6 week old) and infant (7 day old) mice were intranasally inoculated with
pneumococci using a small volume and without anesthesia to prevent aspiration
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into the lower respiratory tract. At different timepoints, bacterial density was
measured by plating nasal lavages for CFUs. Adult mice started to clear
colonization within a week after bacterial challenge, and had fully cleared
pneumococci from the nasopharynx by 21 days postinoculation. By contrast, mice
inoculated as infants maintained pneumococcal carriage for multiple weeks, and
only started to clear colonization at 21 days postinoculation (Fig. 1A). Increased
bacterial loads in infant mice at later timepoints did not reflect differences in
bacterial replication or localization within the nasopharynx (data not shown).
Delayed clearance in infant mice was not a strain-specific effect, as it was also
seen with a clinical isolate of a different pneumococcal serotype (Fig. 1B). The
effect of age at inoculation waned over time, as seen by the gradual decrease in
colonization by 21 days postinoculation in mice inoculated at 7, 14 or 24 days, or
6 weeks old (Fig. 1C).

Infant mice are impaired in macrophage recruitment during
colonization
Since pneumococcal clearance in adults is dependent on the sustained presence
of macrophages into the nasopharynx, (271) we examined whether macrophages
infiltrated the airway lumen of infant mice. We used flow cytometry to quantify
different cell populations in nasal lavages, and found the macrophage influx into
the nasopharynx was delayed in infant mice compared to adults (Fig. 2A).
Inflammatory responses were not completely absent in infants, however, as the
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acute neutrophil influx was equivalent between adult and infant mice (Fig. 2B).
Furthermore, infant and adult mice were equally capable of mounting a humoral
immune response to colonization, as measured by serum titers of antibodies
specific to the colonizing strain of pneumococci (Fig. 2C). In adult mice, the
pattern recognition receptors Nod2 and TLR2 play redundant roles in
macrophage recruitment and eventual clearance following pneumococcal
colonization (49). The infant clearance defect was epistatic with these pathways,
as there was no additional delay in clearance of colonization in infant mice
deficient in these pattern recognition receptors, implying that the infant
clearance defect was redundant with these pathways (Fig. 2D).

Infant mice do not form a gradient of CCL2 expression during
colonization
Previous work in adult mice demonstrated that induction of the monocyte/
macrophage chemoattractant protein CCL2 (MCP-1) during colonization was
required for clearance (49). Colonized infants, however, did not upregulate Ccl2
expression in the upper respiratory tract epithelium relative to expression in
mock infants, as measured by qRT-PCR on RNA isolated from nasal lavages with
RLT lysis buffer (Fig. 3). When directly comparing Ccl2 expression in mockinfected adult and infant mice, baseline levels were significantly higher in the
infant URT than the adult (Fig. 3). As with other chemokines, a gradient of CCL2
is required to attract macrophages (206). The lack of induction of Ccl2 in infant
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mice during colonization suggested the gradient of this macrophage-attracting
chemokine was absent.

CCL2 overexpression accelerates pneumococcal clearance
To artificially induce a gradient of CCL2 in infant mice, we infected 4 day-old
infant mice with AAV vectors expressing GFP (mock/vector control) or murine
CCL2. Three days later, mice were colonized with pneumococci. At 7 days
postinoculation (dpi), mice were sacrificed, nasal lavages obtained and flow
cytometry performed to assess the macrophage influx into the nasopharyngeal
lumen. The delay in macrophage recruitment in infant mice was recovered by
ectopic CCL2 overexpression (Fig. 4A). We assessed whether macrophage
recruitment was sufficient to accelerate pneumococcal clearance by measuring
colonization density at 21 dpi, and found only a slight recovery of the infant
defect in clearance (Fig. 4B). CCL2 overexpression in the URT appeared to create
a local gradient in CCL2, as mice infected with the CCL2-expressing vector
exhibited increased Ccl2 transcription (Fig. 4C) and CCL2 expression (Fig. 4D),
while CCL2 expression in serum was unchanged (Fig. 4E).

Depleting the microbiota limits infant Ccl2 expression and accelerates
pneumococcal clearance
Having found that infant mice have higher levels of Ccl2 expression in the URT
and delayed macrophage recruitment and pneumococcal clearance that wanes
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over time, we next asked what the source of elevated CCL2 in infants could be.
Among the changes infants experience during normal development is the
acquisition of a stable microbiota (195). We examined whether the microbiota
contributed to CCL2 expression by treating the drinking water of mice with
antibiotics to deplete the flora. Adult mice were directly exposed to antibiotictreated drinking water, while infant mice were exposed indirectly by treating the
water of the dams from which the infants nursed. This indirect exposure was
sufficient to decrease the commensal flora of the infant upper respiratory tract
(Fig. 5A). Antibiotic treatment had no effect on URT expression of Ccl2 in adults,
but decreased infant Ccl2 expression to adult levels (Fig. 5B). Limiting baseline
Ccl2 expression in the URT of infants allowed for normal responses to
pneumococcal colonization, as macrophages were recruited into the nasopharynx
of antibiotic-treated infant mice following 7 days of pneumococcal colonization,
unlike tap-water treated mice (Fig. 5C). Even though antibiotics were removed
from the drinking water starting 24 hrs before pneumococcal challenge in these
experiments, it was still possible that any residual antibiotics could have direct
effects on pneumococcal density in the nasopharynx. To exclude this possibility,
we measured bacterial load at 7 dpi, before the onset of clearance. Prior antibiotic
treatment had no effect on the density of colonizing pneumococci at 7 dpi (Fig.
5D), but accelerated clearance at 14 dpi (Fig. 5E).
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Infant mice have systemic alterations in CCL2 signaling

Antibiotic treatments demonstrated an effect of the microbiota on tonic CCL2
signaling in infant mice, but it remained unclear whether the microbiota acted
locally in the airway or systemically from distal sites such as the gut to trigger
URT CCL2 signaling tonically. Infant mice exhibited higher serum levels of CCL2
protein, suggesting a systemic effect on CCL2 (Fig. 6A). To address whether there
were systemic alterations in CCL2 signaling, we examined a distal, sterile site that
lacks a local flora, the peritoneal cavity. We elicited macrophages from the
peritoneal cavity by intraperitoneally injecting thioglycollate, followed 3 days
later by peritoneal lavage to obtain cells. Macrophages were purified by
adherence, and then stimulated either with PBS (mock) or heat-killed
pneumococci for 24 hrs. RNA was harvested from cells, and qRT-PCR performed
to measure expression of Ccl2. Ccl2 expression was higher in infant macrophages
than adults at baseline, and did not increase further on stimulation with heatkilled bacteria, unlike expression in stimulated adult macrophages (Fig. 6B). This
tonic increase in Ccl2 production by systemic macrophages was accompanied by
a decrease in infant Ccr2 production (Fig. 6C). The decrease in Ccr2 expression
did not reflect a general downregulation of surface receptors in infant
macrophages, however, as levels of the scavenger receptors Marco (Fig. 6D) and
Cd36 (Fig. 6E) were unchanged. We used flow cytometry on peritoneal lavage
fluid to measure the proportion of hematopoietically-derived cells that were
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macrophages. Infant mice had a higher proportion of peritoneal cells that were
macrophages compared to adults, indicative of systemic alterations in
macrophage trafficking (Fig. 6F). This effect slowly decreased with age,
paralleling the gradual increase in clearance of pneumococcal colonization, and
was rescued by antibiotic treatment of nursing dams (Fig. 6F-G). Furthermore,
thioglycollate treatment, which has previously been shown to recruit
macrophages into the peritoneal cavity in a CCL2-dependent manner, (120)
increased the proportion of peritoneal macrophages in adult mice, but had no
effect on the already elevated levels of macrophages found in infants (Fig. 6H).
Collectively, these results indicated infant mice had systemically altered CCL2
regulation.

The microbiota controls infant expression of proinflammatory signals
We next sought to determine how broad the effects of the microbiota were on
proinflammatory signals in infant mice. We used qRT-PCR to measure the
expression of Ccl7, a monocyte/macrophage chemoattractant related to Ccl2, and
found tonically elevated URT levels in infant mice that were decreased to adult
levels by antibiotic treatment (Fig. 7A). The same pattern was seen when
examining expression of the proinflammatory cytokine Il6 (Fig. 7B). Since IL17
signaling has been found to contribute to CCL2 expression, (210) we examined
expression of Il17a as a potential source of tonically elevated CCL2 in infants. The
infant URT expressed more Il17a at baseline than did adult mice, which was
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decreased to adult levels by depleting the microbiota, implying that elevated IL17
stimulated by the infant microbiota may underlie higher CCL2 levels (Fig. 7C).

Discussion
Pneumococcal colonization and disease are more common in children than
adults, but the mechanism underlying this predisposition has not been clear.
Here, we demonstrated that an infant mouse model of carriage recapitulates the
human delay in pneumococcal clearance. Using this model, we found that infant
mice have delayed macrophage responses during colonization, which correlated
with a failure to upregulate CCL2 signaling. Infant mice had tonic CCL2
production in the URT, indicating a loss of chemokine gradient. Reestablishing a
gradient by ectopic overexpression of CCL2 restored macrophage recruitment
and contributed to pneumococcal clearance. We found that the microbiota
contributed to tonic CCL2 expression, as depleting the commensal flora lowered
CCL2 levels, restored normal macrophage responses and accelerated clearance of
pneumococcal colonization. This effect was seen even 14 days after stopping
antibiotic treatment. Infant mice had systemic alterations in CCL2 signaling, as
seen in cells isolated from the peritoneum, a distal, sterile site. Other
proinflammatory transcripts were further upregulated in the infant URT in a
manner dependent on the microbiota, and higher tonic IL17A levels could point
to a potential mechanism for this effect.
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Higher pneumococcal loads in the infant nasopharynx have been previously
reported, (21) but this prior work did not examine innate immune responses in
vivo that could explain delayed bacterial clearance, such as macrophage
recruitment or expression of a gradient of CCL2. Another study found delayed
pneumococcal clearance in elderly mice, which correlated with decreased
monocytic phagocyte recruitment and an increased inflammatory state at
baseline in elderly mice (110). This study did not find a role for elevated CCL2
expression in aged mice, however (110). There is a growing understanding that
overly exuberant inflammatory responses can be found both early and late in life,
both in humans and mice (108). It would be important to determine whether
alterations in CCL2 signaling specifically fit this pattern as well.

We found tonically elevated CCL2 expression in the URT of infant mice, which
was dependent on the presence of the microbiota in infant mice. Depleting the
microbiota with antibiotic-treated water had no effect on adult CCL2 production,
though it was not clear whether the effect was restricted to infants due to the
specific flora found in infant mice or a response unique to the infant host. The
mechanism by which the infant URT responds to the presence or acquisition of
the microbiota by increasing production of CCL2 and other inflammatory
mediators remains unknown. Signaling events in the URT could reflect sensing of
the local airway flora, or of commensals at distal sites such as the gut. The
systemic alterations in infant CCL2 expression suggest a non-local effect, as even
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sterile sites such as the peritoneal cavity contained macrophages with altered
CCL2 signaling. It is also unclear how the microbiota exerts its effects on CCL2
signaling. The infant gut in mice is porous until weaning, (228) which could
promote leakage of microbial products outside the containment of the gut lumen
into otherwise sterile sites, potentially explaining the more robust
proinflammatory responses seen in infant mice at sites distal to the gut. Though
TLR2 and Nod2 had no role in the infant defect in colonization clearance, other
TLRs or additional pattern recognition receptors could contribute to sensing the
infant microbiota. Constitutive intestinal epithelial NF-#B activity is present in
infant mice, and may be associated with endotoxin tolerance (61). Alternatively or
additionally, sensing of microbial products that stimulate inflammation in infants
may occur locally at the site of commensal colonization, with systemic effects by
the expression of signals such as IL-17A.

The pattern of increased infant CCL2 expression that could be reduced by
depleting the microbiota was also found for two other proinflammatory
mediators, the related monocyte chemoattractant CCL7 and IL-17A. It is possible
that IL-17 production, by inducing NF-#B activity, could lie upstream of both
CCL2 and CCL7 expression. IL-17 itself could be overproduced in infants exposed
to a commensal flora for the first time, as specific constituents of the flora in
adult mice have been shown to promote Th17 cell development (83). It is also
unclear how broad the infant alterations in proinflammatory signals extend;
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neonatal mice have previously been described to exhibit delayed T cell
recruitment into the lungs during influenza infection, (117) suggesting alterations
in chemokines other than monocyte chemoattractants.

We also found macrophage recruitment to the infant murine nasopharynx was
delayed during pneumococcal colonization. There is precedent for this pattern in
humans as well, as the number of macrophages recruited to the nasal lumen
during URT infections increased with age (243). This effect was independent of
the number of prior infections (243). There is some evidence that human infants
exhibit similar patterns of CCL2 production to what was observed in infant mice
here. One study found that serum CCL2 levels in normal children were higher
(125 pg/mL) than those found in normal adults (89 pg/mL) (53). Another study,
however, found no relationship between age and serum CCL2 levels in normal
controls (67). Further studies of CCL2 and macrophage responses in human
samples could resolve these discrepancies. Macrophages from the peritoneal
cavity of adults and infants expressed markers of M1 and M2 polarization
equivalently (data not shown).

Altered monocyte/macrophage trafficking and CCL2 signals could be particularly
important in mediating infant susceptibility to other infections, such as those
with Listeria monocytogenes, which require both CCL2 and recruited monocytederived cells for clearance (208). As a result, the mechanisms described here may
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reflect a general defect in infant innate immune responses and extend beyond
pneumococcal carriage to clearance of other mucosal agents. Neonatal infections
are commonly caused by encapsulated bacteria, including additional
opportunistic pathogens that colonize the URT (253). Host factors required for
clearance of these other respiratory pathogens are not as well-defined as those for
pneumococci.

Materials and Methods

Mice
C57Bl/6 mice were obtained from Jackson Laboratory. Adult and infant mice
used were bred in the John Morgan animal facility at the University of
Pennsylvania. Procedures were carried out according to an animal protocol
approved by the University of Pennsylvania IACUC.

Bacterial strains and colonization
Pneumococcal strains used were TIGR4 (capsule type 4) (234) and P1121 (capsule
type 23F), (135) clinical isolates from invasive infection and human colonization,
respectively. For mouse colonization, pneumococci were grown in tryptic soy
broth at 37º C until mid-log phase, then resuspended in sterile PBS. Adult mice
were colonized with 107 CFU bacteria in a volume of 10 µL, while infant mice
were colonized with 2x103 CFU in a volume of 3 µL. Mice were sacrificed at
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indicated timepoints, and nasal lavages obtained with 200 µL sterile PBS.
Lavages were diluted onto TS agar with catalase (5,000 U/plate) (Worthington
Biochemical) and 5 µg/mL neomycin added for quantitative culture at 5% CO2.

Flow Cytometry
Nasal lavages were fixed in 2% paraformaldehyde, and then stained with
antibodies to identify macrophages and neutrophils: anti-Ly6G (clone 1A8), antiCD11b and anti-F4/80. Peritoneal lavages were fixed and stained with antibodies
to identify peritoneal macrophages and other myeloid populations, including a
live/dead stain, anti-Ly6G, anti-Ly6C, anti-CD11b and anti-F4/80 antibodies.
Samples were run on FACS Calibur and FACS Canto instruments (Becton
Dickinson) and analysis performed using FlowJo software (Tree Star).

ELISA
For measurements of anti-pneumococcal antibody titers, pneumococcal strain
P1121 was grown and resuspended to an OD620 of 0.1 in coating buffer (0.015 M
Na2CO3, 0.035 M NaHCO3), then plated onto Immulon 2HB 96-well plates
(Thermo) at 4˚C overnight. Plates were washed with 0.05% Brij in PBS, and
blocked for 1 hr at 37˚C in 1% BSA in PBS. After additional washes, serum
samples were added in serial 2-fold dilutions (made in 1% BSA in PBS) and
incubated overnight at 4˚C. Anti-pneumococcal antibodies were detected by
incubating for 1.5 hrs at room temperature with an alkaline phosphatase98

conjugated goat anti-mouse IgG antibody, followed by developing for 1 hr at 37˚C
with p-nitrophenyl phosphatase. Absorbance was measured at 415 nm. For
measurements of CCL2 protein levels in serum and nasal lavages, an ELISA kit
was used according to the manufacturer’s protocol (eBioscience).

qRT-PCR
RNA was obtained from URT epithelium by lavage with RLT buffer with 1% !mercaptoethanol, or from cultured peritoneal macrophages by lysing cells in RLT
buffer with 1% !-mercaptoethanol. An RNeasy kit (Qiagen) was used to isolate
RNA, and cDNA reverse transcribed by the High-Capacity cDNA Reverse
Transcription kit (Applied Biosystems). qRT-PCR reactions were performed with
Sybr Green (Applied Biosystems) with 10 ng cDNA and 0.5 µM primers. The
""CT method was used to compare conditions. Primer sequences were as
follows: GAPDH-F 5’-AGG-TCG-GTG-TGA-ACG-GAT-TTG-3’; GAPDH-R 5’TGT-AGA-CCA-TGT-AGT-TGA-GGT-CA-3’; (17) CCL2-F 5$-AGC-TCT-CTC-TTCCTC-CAC-CAC-3$; CCL2-R: 5$-CGT-TAA-CTG-CAT-CTG-GCT-GA-3$; (49)
CCL2ORF-F 5’-TTA-AAA-ACC-TGG-ATC-GGA-ACC-AA-3’; CCL2ORF-R 5’-GCATTA-GCT-TCA-GAT-TTA-CGG-GT-3’; CCR2-F 5’-GGT-CAT-GAT-CCC-TATGTG-G-3’; CCR2-R 5’-CTG-GGC-ACC-TGA-TTT-AAA-GG-3’; (22) MARCO-F 5’GGC-ACC-AAG-GGA-GAC-AAA-3’; MARCO-R 5’-TCC-CTT-CAT-GCC-CATGTC-3’; (54) CD36-F 5’-GAG-CAA-CTG-GTG-GAT-GGT-TT-3’; CD36-R 5’-GCAGAA-TCA-AGG-GAG-AGC-AC-3’; (168) CCL7-F 5’-GCT-GCT-TTC-AGC-ATC99

CAA-GTG-3’; CCL7-R 5’-CCA-GGG-ACA-CCG-ACT-ACT-G-3’; IL6-F 5’-AGTTGC-CTT-CTT-GGG-ACT-GA-3’; IL6-R 5’-TCC-ACG-ATT-TCC-CAG-AGA-AC-3’;
(78) IL17A-F 5’-TTT-AAC-TCC-CTT-GGC-GCA-AAA-3’; IL17A-R 5’-CTT-TCCCTC-CGC-ATT-GAC-AC-3’

AAV
For overexpression, an AAV vector with the capsid from serotype AAV5 was used
that expressed the open reading frame of murine CCL2, or GFP for the vector
control, under the control of the chicken-beta actin promoter (Vector BioLabs).
Vectors were concentrated to ~1013 GC/mL, and each mouse was inoculated with
1011 GC of vector.

Antibiotic treatment
For antibiotic treatment, tap water was supplemented with 0.5 g/L ampicillin
(Sigma), neomycin (Calbiochem), gentamicin (Invitrogen) and metronidazole
(Sigma), as well as 0.25 g/L vancomycin (Santa Cruz Biotechnology), then sterilefiltered. Water was changed every 4-5 days.

Peritoneal macrophages
Macrophages were either obtained from mice that were unstimulated or were
elicited by intraperitoneal injection of 4% thioglycollate, followed 3 days later by
peritoneal lavage. Cells were isolated by peritoneal lavage with cold sterile PBS,
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then spun down and resuspended in DMEM + 10% FBS. Cells were counted and
adjusted to equal concentrations, then plated on 24-well non-tissue culture
treated plates. After 2 hrs to allow macrophages to adhere, wells were washed 3
times and then media added back. Cells were used for further treatments or RNA
isolation after an overnight incubation.

Statistical analysis
Comparisons were made using Prism software (Graphpad). Comparisons
between groups for colonization data were made by Mann-Whitney U-test or
Kruskal-Wallis test with Dunn’s posttest for two and three or more groups,
respectively. All other comparisons were made by unpaired t-test or 1-way
ANOVA with Newman-Keuls posttest for two and three or more groups,
respectively.
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Figure Legends

Figure 1: Pneumococcal carriage is prolonged in infant mice

(A) Adult (6 weeks old) and infant (7d old) mice were inoculated with 107 or
2x103 colony forming units (CFU) of pneumococcal strain P1121, respectively. At
the indicated number of days postinoculation (dpi), mice were sacrificed and
nasal lavages obtained and plated to determine the load of colonizing
pneumococci. (B) Adult and infant mice were inoculated with pneumococcal
strain TIGR4 (type 4). Mice were sacrificed at 21 dpi and nasal lavages obtained
and plated to determine the load of colonizing pneumococci. (C) Mice were
inoculated with strain P1121 (type 23F) at different ages, ranging from 7 days to 6
weeks. At 21 dpi, mice were sacrificed and nasal lavages obtained and plated to
measure bacterial density in the nasopharynx. Points in (A) represent mean +/SEM. Horizontal lines indicate median values. Dotted lines indicate limit of
detection. * = p < 0.05, *** = p < 0.001.

Figure 2: Infant mice are impaired in macrophage recruitment during
colonization
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(A-B) Adult (6 week old) and infant (7d old) mice were inoculated with P1121 for
the indicated number of days. Nasal lavages were obtained and fixed and stained
for flow cytometry to identify macrophages (F4/80+, CD11b-) and neutrophils
(CD11b+, Ly6G+). (C) Serum was obtained from adult and infant mice colonized
with pneumococci for 21 days, or mock-colonized. Samples were analyzed by
ELISA for the presence of antibodies specific to strain P1121. (D) Infant mice of
the indicated genotype were colonized at 7d old. Mice were sacrificed at the
indicated timepoints and nasal lavages obtained and plated to measure bacterial
load. Data are represented as mean +/- SEM. * = p < 0.05.

Figure 3: Infant mice do not form a gradient of CCL2 expression
during colonization

Adult (6 week old) and infant (7d old) mice were inoculated with PBS (mock) or
pneumococci for 3d. Nasal lavages were obtained with RLT lysis buffer, and RNA
was isolated and reverse transcribed to cDNA. qRT-PCR was performed to
measure relative expression of Ccl2. Data are represented as mean +/- SEM. n.s.,
not significant. * = p < 0.05, *** = p < 0.001.

Figure 4: CCL2 overexpression is not sufficient to accelerate
pneumococcal clearance
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(A) Mice were inoculated with a control (GFP-expressing) or a CCL2-expressing
AAV5 vector at 4d old, followed by pneumococcal colonization at 7d old. Seven
days later, mice were sacrificed. Nasal lavages were obtained, fixed and stained
for flow cytometry to measure the number of macrophages infiltrating the airway
lumen. (B-E) Mice were inoculated with a control (GFP-expressing) or a CCL2expressing AAV5 vector at 4d old, followed by pneumococcal colonization at 7d
old. Twenty-one days later, mice were sacrificed and nasal lavages obtained and
plated to measure the pneumococcal load in the nasopharynx (B). Nasal lavages
were also obtained with RLT lysis buffer. RNA was isolated and cDNA reversetranscribed, followed by qRT-PCR to measure the relative expression of Ccl2 in
the upper respiratory tract, using primers CCL2ORF-F and CCL2ORF-R (C).
ELISA was used to measure CCL2 protein levels in nasal lavage (D) and serum
(E). Horizontal lines indicate median values. Data are represented as mean +/SEM. n.s., not significant. * = p < 0.05, *** = p < 0.001.

Figure 5: Depleting the microbiota limits infant Ccl2 expression and
accelerates pneumococcal clearance

(A) Breeding pairs were placed on sterile filtered tap water or water containing 5
antibiotics for at least 5 days prior to giving birth, and continued until the infant
mice were 10d old. Mice were sacrificed, and nasal lavages obtained with PBS.
Bacterial DNA was isolated from lavage fluid, and qPCR used to measure relative
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expression of 16S bacterial ribosomal DNA. (B) Adult mice were maintained on
sterile filtered tap water or water containing 5 antibiotics for at least 2 weeks.
Breeding pairs were placed on sterile filtered tap water or water containing 5
antibiotics for at least 5 days prior to giving birth, and continued until the infant
mice were 10d old. Mice were sacrificed, and nasal lavages obtained with RLT
lysis buffer. RNA was isolated and reverse-transcribed into cDNA, and qRT-PCR
was used to measure relative expression of Ccl2 in the nasopharynx. (C) Infant
mice were exposed to tap water or antibiotics as in the previously described
protocol for at least 5 days prior to birth. Water treatments were continued until
the infant mice were 6d old. 24 hrs later, mice were inoculated with
pneumococci. At 7 dpi, mice were sacrificed and nasal lavages were fixed and
stained for flow cytometry to measure the number of macrophages present in the
airway lumen. (D-E) Infant mice were treated as in (C). At the indicated
timepoint (7 or 14 dpi), mice were sacrificed. Nasal lavages were obtained and
plated to measure the bacterial density in the URT. Data are represented as mean
+/- SEM. Horizontal lines indicate median values. n.s., not significant. * = p <
0.05, ** = p < 0.01, *** = p < 0.001.

Figure 6: Infant mice have systemic alterations in CCL2 signaling

(A) Serum was isolated from mock-inoculated adult and infant mice, and CCL2
protein levels measured by ELISA. (B) Peritoneal macrophages were isolated
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from adult (6 week old) and infant (10d old) mice. Macrophages were stimulated
with PBS (mock) or heat-killed pneumococci for 24 hrs. Cells were lysed with
RLT buffer. RNA was isolated and reverse-transcribed to cDNA, followed by qRTPCR to measure relative expression of Ccl2. (C-E) Unstimulated peritoneal
macrophages were lysed with RLT buffer. RNA was isolated and reversetranscribed to cDNA, followed by qRT-PCR to measure relative expression of
Ccr2 (C), Marco (D) and Cd36 (E). (F) Flow cytometry was performed on
peritoneal lavage fluid isolated from mice at the indicated ages, and the percent
of live, CD45+ cells that were macrophages (F4/80+, CD11b+) was measured. (G)
Adult mice were maintained on sterile filtered tap water or water containing 5
antibiotics for at least 2 weeks. Breeding pairs were placed on sterile filtered tap
water or water containing 5 antibiotics for at least 5 days prior to giving birth,
and continued until the infant mice were 10d old. Mice were sacrificed, and
peritoneal lavages obtained and fixed and stained for flow cytometry. The percent
of live, CD45+ cells that were macrophages (F4/80+, CD11b+) was measured. (H)
Adult (6 week old) and infant (7d old) mice were intraperitoneally inoculated
with PBS (mock) or thioglycolate (TG). Three days later, peritoneal lavages were
obtained, fixed and stained for flow cytometry. The percent of live, CD45+ cells
that were macrophages (F4/80+, CD11b+) was measured. Data are represented as
mean +/- SEM. n.s., not significant. * = p < 0.05, ** = p < 0.01, *** = p < 0.001.
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Figure 7: The microbiota controls infant expression of
proinflammatory signals

(A-C) Adult mice were maintained on sterile filtered tap water or water
containing 5 antibiotics for at least 2 weeks. Breeding pairs were placed on sterile
filtered tap water or water containing 5 antibiotics for at least 5 days prior to
giving birth, and continued until the infant mice were 10d old. Mice were
sacrificed, and nasal lavages obtained with RLT lysis buffer. RNA was isolated
and reverse-transcribed into cDNA. qRT-PCR was used to measure relative
expression of Ccl7 (A), Il6 (B) and Il17a (C). Data are represented as mean +/SEM. * = p < 0.05.
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Abstract

While the importance of transmission of pathogens is widely accepted, there is
currently little mechanistic understanding of this process. Nasal carriage of
Streptococcus pneumoniae (the pneumococcus) is common in humans,
especially in early childhood, and is a prerequisite for the development of disease
and transmission among hosts. In this study, we adapted an infant mouse model
to elucidate host determinants of transmission of S. pneumoniae from inoculated
index mice to uninfected contact mice. In the context of co-infection with
influenza A virus, the pneumococcus was transmitted among wildtype
littermates, with approximately half of the contact mice acquiring colonization.
Mice deficient for TLR2 were colonized to a similar density but transmitted S.
pneumoniae more efficiently (100% transmission) than wildtype animals and
showed decreased expression of interferon % and higher viral titers. The greater
viral burden in tlr2-/- mice correlated with heightened inflammation, and was
responsible for an increase in bacterial shedding from the mouse nose. The role
of TLR2 signaling was confirmed by intranasal treatment of wildtype mice with
the agonist Pam3Cys, which decreased inflammation and reduced bacterial
shedding and transmission. Taken together, these results suggest that the innate
immune response to influenza virus promotes bacterial shedding, allowing the
bacteria to transit from host to host. These findings provide insight into the role
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of host factors in the increased pneumococcal carriage rates seen during flu
season and contribute to our overall understanding of pathogen transmission.

Author summary

In this study, we sought to identify factors contributing to the transmission of the
bacterial pathogen Streptococcus pneumoniae (the pneumococcus), a major
cause of otitis media, pneumonia and septicemia. Often found as a co-infection
with other bacterial and viral pathogens, the pneumococcus is commonly carried
by young children and is spread by close human contact, most likely through
large droplet respiratory secretions. The specific determinants of bacterial
transmission, however, have not been identified. This report details our use of an
infant mouse model of transmission, which includes influenza A co-infection, to
elucidate the mechanism of host-to-host transmission. We found that the
inflammatory response to influenza, which is aggravated in the context of
weakened host defense, promotes transmission by inducing bacterial shedding
from the mouse nose. These results show how a bacterial pathogen exploits the
host immune response to spread from one host to the next.
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Introduction
The bacterial pathogen Streptococcus pneumoniae (the pneumococcus) robustly
colonizes the upper respiratory tract of humans and is commonly carried
asymptomatically. Colonization rates are highest in early childhood, where they
can exceed 80% (19); in crowded environments such as daycare centers (192);
and when viral respiratory infections are prevalent (80). The bacterium can
invade other host sites from its niche in the nasopharynx, and as a result the
pneumococcus is a leading cause of otitis media, pneumonia, and septicemia.
Importantly, colonization of the nasopharynx is the reservoir for pneumococcal
disease (65, 220, 224, 230) and transmission between hosts (119, 197). While
pneumococcal colonization and disease have been well-studied using animal
models (for review see (146, 262)), transmission of the bacterium remains poorly
understood. In humans, close contact is required for transmission, which is
thought to occur via respiratory secretions, but the specific host and bacterial
factors contributing to this process have not been elucidated (94, 155).

Recently, an infant mouse model of pneumococcal transmission has been
described (52). In this model, ‘index’ mice are given Streptococcus pneumoniae
intranasally and co-housed with uninoculated ‘contact’ littermates. Subsequently,
all pups are inoculated with influenza A virus and, following an exposure period,
transmission from index to contact mice is assessed by enumerating bacteria in
the nasopharynx. Using this model, this group demonstrated that both increasing
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the bacterial titer in the index mice and inducing inflammation in the contact
mice led to more efficient transmission (217). Given the timing of these
experiments, these studies suggest a role for the innate immune response in the
setting of co-infection in transmission of the pneumococcus from host to host.

The host immune response to influenza has been extensively reviewed (162, 244)
and is briefly summarized here to highlight key elements. After passing through
the mucus layer lining the respiratory tract, influenza A virus is recognized by
several pattern recognition receptors (PRRs) expressed by epithelial cells,
including the Toll-like receptors (TLRs), nucleotide oligomerization domain-like
receptors (NLRs), and retinoic acid-inducible gene-I receptors (RIG-I).
Engagement of these receptors induces a signaling cascade that culminates in
expression of interferons (IFNs) and pro-inflammatory cytokines and
chemokines, resulting in recruitment and activation of immune cells, such as
neutrophils and macrophages. A recent study has shown that influenza infection
also leads to increased mucin expression by epithelial cells in the respiratory tract
(14).

TLR2 has been implicated in promoting clearance of the pneumococcus (49, 271),
and stimulation of this receptor has been shown to protect against influenza
infection (232). Additionally, recent work has shown that signaling through TLR2
can induce anti-viral responses after stimulation by viral and synthetic ligands
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(13, 179). Thus, we hypothesized that mice deficient for TLR2 would display
altered transmission of the bacterium in this model. We found that mice deficient
in TLR2 show heightened acute inflammation in index mice and enhanced
transmission due to an increase in number of bacteria shed via nasal secretions.
This model recapitulates many facets of human-to-human transmission of
pneumococcal carriage, such as concurrent viral infection and close contact
between infants/children, and these findings provide insight into how innate
immune responses to infection promote the spread of pathogens from host to
host.

Results

S. pneumoniae is transmitted between wildtype hosts in the context
of influenza co-infection.
Our adaptations to the previously reported infant mouse model of pneumococcal
transmission are outlined in the schematic in Figure 1A (52). In these
experiments, four-day-old pups were intranasally inoculated with pneumococci
(index mice only) and on day 8 all mice in the litter (both index and contacts)
were intranasally inoculated with Influenza A/HKx31 (mouse-adapted H3N2)
virus. On day 14, the pups were sacrificed and bacterial loads were enumerated in
nasal lavages. In wildtype mice, acquisition of colonization was detected in
approximately half (47%) of the contact pups (Figure 1B, flu). In contrast, without
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influenza (PBS administered at day 8), none of the contact pups acquired S.
pneumoniae (Figure 1B, mock). Moreover, transmission was not simply due to
increased bacterial load in the index mice, as there was no significant difference
between the mock or flu index groups. This phenotype makes this model
particularly useful for probing the factors that limit and promote bacterial
transmission because transmission can be either increased or decreased by
experimental manipulations.

As this infection model utilizes a six-day exposure period, it is possible that
contact mice infected early in that window could then go on to spread the
bacteria to other contacts. In order to test this possibility, we repeated the initial
experiment but gave S. pneumoniae to the index (“inoculated contact”) on day 9
instead of day 4, to simulate acquisition from an index mouse. These inoculated
contacts were able to spread infection effectively, with four out of five
“uninoculated contact” mice acquiring colonization (Figure S1). The observed
transmission among contact mice makes it unlikely that the ratio of index to
contact mice was a significant factor in overall rates of transmission.

Mice lacking TLR2 display increased pneumococcal transmission.
We then repeated the transmission experiment using tlr2-/- mice. All tlr2-/contact mice acquired pneumococcal colonization and were colonized at high
levels (Figure 2A). As TLR2 deficiency led to increased transmission, we reasoned
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that stimulation of TLR2 could limit bacterial spread. To test this, we performed
a transmission experiment with wildtype mice and intranasally administered the
TLR2 agonist Pam3Cys three times over the course of the exposure period (days
8, 10, and 12). As depicted in Figure 2B, transmission was significantly less
efficient in treated animals than in control litters, with only one mouse out of
sixteen acquiring colonization.

We hypothesized that the increase in transmission efficiency seen in tlr2-/animals could be due to either increased spread by the index mice or increased
susceptibility in the contact mice. To address this question, we assessed whether
the transmission phenotype was dependent on the index or contact mice in a
mixed litter experiment. Age-matched litters of wildtype and tlr2-/- mice were
inoculated with S. pneumoniae as described above, but the index mice from each
litter were switched, such that tlr2-/- index were co-housed with wildtype contacts
and wildtype index were co-housed with tlr2-/- contacts. After the six-day
exposure period, only 39% of the tlr2-/- contacts housed with wildtype index mice
had detectable levels of colonization (Figure 2C). This was not significantly
different from the wildtype contact group in the previous experiments, but was
significantly different from the tlr2-/- contact group (p = 0.0014). On the
contrary, 89% of wildtype contacts housed with tlr2-/- index mice became infected
(Figure 2C). This was not significantly different from the tlr2-/- contact group, but
was significantly different from the wildtype contact group (p = 0.0013). These
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results indicate that the increased transmission phenotype seen in the tlr2-/- mice
is linked to the index mouse, which we postulated was due to increased spread of
the bacterium from these mice. However, this effect was not due to an increased
bacterial load in the tlr2-/- mice compared to the wildtype. We thus concluded
that TLR2 deficiency likely did not cause an increase in susceptibility to bacterial
acquisition in this model.

Influenza infection results in neutrophil influx to the nasopharynx.
We next assessed the innate immune response to infection with influenza and
pneumococcus, both separately and in the context of co-infection, in our infant
mouse model. To test this, we infected wildtype mice as index pups according to
the schematic in Figure 1A, giving PBS doses when appropriate for single or
mock-infected groups. Nasal lavage was performed on day 14, and a sample of
lavage fluid was stained with antibodies against a panel of immune cells (Ly6G,
CD11b, F4/80 and CD4). While no significant influx of macrophages or T cells
was seen (data not shown), we noticed significant differences in neutrophil
populations, as seen in Figure 3A. Neutrophils (Ly6G+ and CD11b+ events)
comprised very little of the total cell count for both mock-infected mice and those
given S. pneumoniae alone. However, when influenza was present, both in single
infection and in co-infection with the pneumococcus, we observed a significant
neutrophil influx, comprising 62.6% and 74.7% of the total cell infiltrate,
respectively (Figure 3A).
124

We also visualized neutrophils and bacteria in the lavage fluid via
immunofluorescence microscopy. The representative image in Figure 3B shows
multiple intact pneumococci associated with a cluster of neutrophils. These
clusters of neutrophils were not seen in mice that were mock infected or infected
with the pneumococcus alone (data not shown). Taking these results together, we
posit that influenza infection sparks neutrophil influx into the nasopharynx, and
that this acute inflammatory response is ineffective at clearing the bacteria, but
facilitates the spread of bacteria amongst littermates.

Mice deficient in TLR2 display increased inflammation.
Based on the observation that TLR2 deficiency led to increased transmission, we
hypothesized that the innate immune response to co-infection with the
pneumococcus and influenza differed between these two groups. When we
analyzed the neutrophil content of lavage fluid from co-infected tlr2-/- mice, we
found neutrophils to make up a significantly higher percentage of the total cells
than in wildtype mice (mean 86.1%, Figure 4A). This was not due to a difference
in response to the pneumococcus, as these percentages were not different
between wildtype and tlr2-/- infected with S. pneumoniae alone (Figure 4A). As
this result suggested that there was more inflammation in co-infected tlr2-/- mice,
we also compared mucus production by analyzing relative expression levels of
Muc5ac, the primary secreted mucin of the nasopharynx, by qRT-PCR (97). We
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found that in co-infected tlr2-/- mice, Muc5ac transcript levels were on average
2.8-fold higher than in co-infected wildtype mice (Figure 4B).

Recent work has shown that TLR2-dependent signaling can induce anti-viral
responses in the form of type I IFN production (13, 179). Considering these
findings, we hypothesized that tlr2-/- mice display a weakened anti-viral
response, rendering them more susceptible to influenza infection leading to
heightened inflammation. To assess the anti-viral responses produced by the
mice used in our model, we examined IFN% expression levels by qRT-PCR at an
early time point after influenza inoculation (3 days) and found that co-infected
tlr2-/- mice showed a 2.6-fold reduction in IFN% transcript compared to wildtype
(Figure 4C). Additionally, levels of viral RNA were 5.4-fold higher in tlr2-/- mice
than wildtype, suggesting that the increased inflammation observed could be due
to increased viral titers in the tlr2-/- host (Figure 4D). This increase in viral levels
was not dependent on the presence of pneumococcus, as evidenced by the ~3-fold
increase in viral RNA in tlr2-/- mice infected with influenza alone. Thus, increased
inflammation appears to be associated with increased transmission of S.
pneumoniae by infected hosts. Supporting this, mice treated with the TLR2
agonist Pam3Cys displayed both lower viral titers (Figure 4E) and subsequently,
less of an inflammatory response, with fewer total cells in the nasopharyngeal
infiltrate (Figure 4F).
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Influenza infection induces bacterial shedding at a level high enough
to infect infant mice.
Taken together, our data have suggested that inflammation promotes bacterial
spread, and thus we hypothesized that increases in inflammation and mucus
production lead to increased bacterial shedding in the form of nasal secretions. In
order to determine the number of bacteria being shed in this manner, we adapted
a method in which the nose of the mouse is gently pressed onto a nutrient agar
plate and exhaled bacteria are then quantified (3). We observed that in both
wildtype and tlr2-/- co-infected mice, detectable levels of bacteria were shed
throughout the experiment, starting on day 10 (Figure 5A,B). When bacterial
counts from days 10-14 are compared between groups, the tlr2-/- mice shed
significantly more bacteria then the wildtype group over the course of the
exposure window (p < 0.0001). As TLR2 deficiency led to increased shedding, we
reasoned that stimulation of this receptor could limit shedding, and thus we
repeated the wildtype shedding experiment, including three intranasal
administrations of Pam3Cys over the exposure period. The treated animals shed
significantly fewer bacteria than the control litter (Figure 5E), demonstrating that
TLR2 stimulation can limit shedding. Bacterial shedding was dependent on
influenza co-infection for both groups, as mice infected with S. pneumoniae alone
did not shed appreciable amounts of bacteria at any point in the experiment
(Figure 5C,D).
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To determine if the numbers of bacteria shed were sufficient to infect contact
mice, we intranasally administered 500 CFU of S. pneumoniae (~ID50 for adult
mice) to 7-day-old pups and assessed colonization levels the following day. We
found that this was a sufficient dose to establish colonization with a robust
increase in bacterial density over the inoculum size in the infant mouse
nasopharynx, with 100% of pups colonized. Most adult mice, in contrast, were
not consistently colonized by this low dose and those that became colonized had
bacterial numbers below that of the inoculum – a result that correlated with the
lack of pneumococcal transmission observed among adult mice (Figure 5F). In
co-infected infant pups, from days 10-14, approximately 14% of wildtype mice
regularly shed >500 colonies, while 43% of tlr2-/- mice consistently shed at this
level or higher, corresponding to the rates of transmission in these two groups. In
contrast, none of the mice given PBS instead of influenza shed above this level.
These experiments suggest that TLR2-dependent inflammation induced by
influenza infection promotes shedding of S. pneumoniae through nasal
secretions, and the contact between infected and uninfected infant mice is
sufficient to mediate bacterial transmission from host to host.

Discussion

This study aimed to expand existing knowledge of the transmission of respiratory
bacterial pathogens by specifically analyzing spread of Streptococcus
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pneumoniae in an infant mouse model. Transmission of bacterial pathogens is
critical to their success but has long been a black box in the study of pathogenesis
due to a lack of tractable animal models. An infant mouse model utilizing
influenza co-infection has been recently introduced (52, 217). These studies have
established a preliminary link between inflammation induced by infection and
spread of the bacterium. Here, we sought to identify specific host factors that
contribute to this process and to gain further insight into the mechanisms
responsible for transmission in this model.

Our results demonstrate a role for the innate immune receptor TLR2 in
transmission of the pneumococcus in a flu-dependent manner. The findings in
our report are consistent with previous studies in adult mice, which suggested
that TLR2 stimulation by either commensal bacteria (255) or a synthetic agonist
(232) is protective against flu infection. Previous in vitro studies have also
demonstrated a role for TLR2-mediated signaling in induction of type I IFNs (13,
179). Our work adds in vivo data to this model, demonstrating that expression of
IFN %, a key component of the anti-viral response, was diminished in tlr2-/- mice
compared to wildtype mice. These findings solidify a link between TLR2 activity
and type 1 IFN expression.

Importantly, influenza co-infection was required for transmission to occur; this
was true for both wildtype and tlr2-/- experimental groups. Both infection with
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influenza alone and co-infection resulted in a significant inflammatory influx to
the nasopharynx, with the largest proportion of the cellular infiltrate comprised
of neutrophils. In tlr2-/- mice, this response was even more pronounced, with a
significantly higher percentage of neutrophils present than in the wildtype
samples, while we did not observe any differences in macrophages or other cell
types recruited. The host response to increased viral titers also correlated with
higher expression of the mucin Muc5ac. We hypothesize that these higher levels
of virus stimulate an exaggerated acute inflammatory response that drives an
increase in nasal secretions, consisting of mucus and inflammatory cells,
providing an exit vehicle for the pneumococcus. As the presence of
pneumococcus adds relatively little to inflammation, our findings suggest that it
is primarily the host response to the virus that provides this vehicle for shedding,
with the bacterium acting as a passenger.

The pneumococcus can thus take advantage of the heightened inflammatory state
present in co-infected index animals. The observation that there is very little
inflammation seen in the context of a pneumococcal single infection explains why
transmission is not detected when the animals are not given influenza. The few
neutrophils that are recruited to the airway lumen in response to pneumococcal
colonization have a limited ability to take up the organism in the absence of
specific antibody, and depletion of neutrophils has no effect on bacterial
clearance in adult singly infected mice (134). Additionally, the neutrophil influx
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observed in influenza-infected lavages did not appear to be effective at lysing the
bacterium, as indicated by the predominance of intact bacterial cells in
immunofluorescence images. Thus, the secretions resulting from robust
inflammation are required for transmission, but this inflammatory response
must also be ineffective at killing the bacterium.

We also demonstrate here that the inflammation induced by influenza infection
promotes bacterial shedding from index mice at or above a level sufficient to
infect uninoculated contact mice. Transmission could be a consequence of
bacterial shedding above this threshold level. We conclude that the increased
inflammation in tlr2-/- mice is due mostly to diminished sensing of the virus and
inability to control viral infection. Another consideration is that while tlr2-/genotype itself does not bias the composition of the host microbiota (241), it
likely causes differences in sensing of the flora. Although previous studies have
shown that the microbiota can affect the immune response to influenza, the
contribution of the colonizing pneumococci to the inflammatory response was
small in comparison to influenza. This was the case even though pneumococcal
colonization itself stimulates TLR2 signaling (271). Thus, it appears that the
increased viral load observed in tlr2-/- mice was sufficient to lead to a heightened
inflammatory response through sensing by other viral PRRs resulting in more
copious purulent mucus secretions. These secretions carry live bacteria, which
are then shed in increased numbers. As the nursing mother piles infant mice in
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close proximity to one another, there are thus ample opportunities for the
bacteria to spread from one host to another. These studies also help to explain
the transmission differences between adult and infant mice, namely that
transmission has not been observed in similarly treated adults because of the
higher inoculum required to establish robust colonization in adults.

This is the first study to implicate a specific host factor in transmission of the
bacterial pathogen S. pneumoniae. While stimulation of TLR2 limits
transmission, approximately half of wildtype contact mice acquire the bacterium,
indicating that other components of the innate immune system must contribute
to the inflammation and shedding necessary for this process. For instance,
stimulation of other pattern recognition receptors that respond to influenza, such
as TLR3, TLR7, and RIG-I, could affect pneumococcal transmission, as shown for
TLR2. Signaling downstream of other viral PRRs has yet to be fully explored in
the context of transmission. The model detailed here thus shows much promise
for investigating these additional microbial and host factors to determine the
complete mechanism behind bacterial shedding and its consequences for host-tohost transmission.
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Materials and Methods

Ethics statement This study was conducted according to the guidelines
outlined by National Science Foundation Animal Welfare Requirements and the
Public Health Service Policy on the Humane Care and Use of Laboratory
Animals. The protocol was approved by the Institutional Animal Care and Use
Committee, University of Pennsylvania Animal Welfare Assurance Number
A3079-01, protocol number 803231.

Bacterial and viral strains and culture conditions. S. pneumoniae strains
were grown statically in tryptic soy broth (BD, Franklin Lakes, NJ) at 37°C in a
water bath. All studies described here utilized strain P1121, a serotype 23F isolate
that has been previously used for human carriage studies (135). Bacteria were
stored in 20% glycerol at -80°C. Influenza A/HKx31 (H3N2) was grown in the
allantoic fluid of 10-day embryonated chicken eggs (B&E Eggs) and stored at
-80°C. Viral concentrations for infection were determined by titration in MadinDarby Canine Kidney cells, as described previously (115).

Mice. All experiments using animals were approved by the Institutional Animal
Care and Use Committee of the University of Pennsylvania, and mice were
housed in accordance with IACUC protocols. Wildtype C57BL/6 mice were
originally obtained from The Jackson Laboratory (Bar Harbor, ME). The tlr2-/133

mice have been described previously (271). All mice were bred and maintained in
a conventional animal facility, and both male and female pups were used.

Infant mouse transmission experiments. Mice were bred under specific
pathogen-free conditions at the University of Pennsylvania. Four days after pups
were born, 1-2 index mice (such that ratio of index:contact was always 1:3 to 1:4)
were randomly selected from each litter and inoculated with 2000 CFU of S.
pneumoniae suspended in 3 µl PBS intranasally. Inoculation was performed
atraumatically with a blunt pipette tip without anesthesia, and index pups were
returned to the litter. When pups were 8 days old, all infants were given 2x102 –
2x104 TCID50 Influenza A/HKx31 in 3 µl PBS intranasally. This H3N2 isolate was
chosen because it replicates well in the mouse upper respiratory tract without
causing disease (115). For mock infections, sterile PBS was given. When
indicated, pups were treated with the TLR2 agonist Pam3Cys on days 8, 10, and
12. Pam3Cys (Invivogen) was resuspended to a concentration of 2 mg/ml in
sterile water, and 10 µg doses were given intranasally. On day 14, all pups were
euthanized by CO2 asphyxiation. To quantify bacteria, the trachea was exposed,
cannulated, and flushed with 200 µl sterile PBS. PBS lavages were serially diluted
and plated on tryptic soy agar containing neomycin (20 µg/ml) to minimize the
growth of contaminants. To obtain RNA from the epithelium, a second lavage
was performed with 600 µl of RLT lysis buffer (QIAGEN) and stored at -80°C
until needed.
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Flow cytometry. Nasal lavage samples (100 µl per mouse) were stained with
the following fluorescent antibodies: CD4-FITC, Ly6G-PE, CD11b-perCP and
F4/80-APC (eBioscience) after blocking with FC Block at 4°C. Cells were then
fixed with 1% paraformaldehyde and assayed using a BD FACSCalibur the
following day. Data were gathered using CellQuest Pro software (BD), analyzed
using FlowJo software (TreeStar), and graphed with Prism 5 (GraphPad).

Immunofluorescence. Undiluted nasal lavage fluid was spotted onto glass
microscope slides and allowed to air-dry, and then fixed and stained essentially
as described (271), using rabbit serum against type 23F pneumococcus (1:5000)
and rat anti-mouse %-Ly6B (1:100, AbD serotec) primary antibodies with antirabbit-Cy3 and anti-rat-FITC conjugated secondary antibodies (both 1:600),
respectively, along with DAPI staining. Immunofluorescence images were
collected using a Nikon Eclipse E600 (Nikon Instruments Inc.) equipped with a
liquid crystal (Micro*Color RGB-MS-C; CRi Inc.) and a charge-coupled device
digital camera.

RNA extraction and qRT-PCR analysis. RNA was isolated from the
epithelium lining the mouse nasopharynx following lavage with 600 µl RLT lysis
Buffer using an RNeasy Mini Kit (QIAGEN) according to the manufacturer’s
instructions. For all experiments except IFN% analysis, lavages were collected at
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day 14. IFN% levels were measured in lavage collected on day 11. cDNA was
generated from each sample using a high-capacity reverse transcription kit
(Applied Biosystems). Approximately 10 ng cDNA was used as a template in
reactions with forward and reverse primers (0.5 µM) and SYBR Green (Applied
Biosystems), according to the manufacturer’s instructions. Reactions were
carried out using the StepOnePlus Real-Time PCR system, and fold changes were
calculated using the ""CT method (Applied Biosystems). GAPDH was used as an
endogenous control. The following primers were used in reactions: influenza
nucleoprotein – F 5’-CAGCCTAATCAGACCAAATG-3’, R 5’TACCTGCTTCTCAGTTCAAG-3’; MUC5AC – F 5’CCATGCAGAGTCCTCAGAACAA-3’, R 5’-TTACTGGAAAGGCCCAAGCA-3’;
GAPDH – F 5’-TGTGTCCGTCGTGGATCTGA-3’, R 5’CCTGCTTCACCACCTTCTTGAT-3’, IFN% – F 5’-TCTGATGCAGCAGGTGGG-3’, R
5’-AGGGCTCTCCAGACTTCTGCTCTG-3’.

Bacterial shedding assay. Infant mice were infected as “index mice” as
described above for the transmission model. From day 8 to day 14, daily sampling
was performed for each mouse, in which the nose of the mouse was gently
pressed onto tryptic soy agar containing neomycin (20 µg/ml) 10 times to obtain
a representative sample. The mouse was then returned to the cage, and exhaled
bacteria were spread across the surface of the plate with a polyester-tipped swab.
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Plates were grown overnight at 37°C with 5% CO2 and colonies were enumerated
the following day.

Mouse colonization. Six to eight-week-old (adult) and seven-day-old (infant)
unanesthetized wildtype C57BL/6 mice were intranasally inoculated with 500
CFU of S. pneumoniae P1121. Twenty-four hours later, mice were sacrificed by
CO2 asphyxiation, and tracheas were exposed and cannulated, then flushed with
200 µl PBS. Lavage fluid was collected from the nares, serially diluted, and plated
on tryptic soy agar. Colonies were enumerated after overnight incubation at 37°C
with 5% CO2.
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Figure legends

Figure 1. S. pneumoniae is transmitted between hosts in an infant
mouse influenza co-infection model. A. Schematic of inoculation schedule.
Listed agents were administered intranasally to unanesthetized mice in a volume
of 3 µl PBS and pups were returned to their mothers. Numbered days refer to age
of mice, which were euthanized on day 14. Nasal lavage was performed with 200
µl PBS, which was then serially diluted and plated on selective agar to obtain
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colony counts. B. Pups were infected and sacrificed as described above, with
“mock” animals receiving 3 µl PBS on day 8 instead of influenza. Bacterial loads
in nasal lavage fluid are shown. Each dot represents one mouse. Open circles
designate index mice, and filled represent contact mice. Statistical significance
was assessed using the Mann-Whitney test. Asterisk indicates p < 0.05.

Figure 2. TLR2 stimulation limits pneumococcal transmission. A.
tlr2-/- mice were infected as described in Figure 1A, and bacterial loads in nasal
lavage fluid of contact mice are shown (filled triangles). Data from wildtype
contacts (replicated from figure 1B) are also shown for comparison (filled circles).
B. Wildtype mice were infected as described in Figure 1A, and all pups were given
Pam3Cys or PBS (vehicle control) intranasally on days 8, 10, and 12. Mice were
sacrificed on day 14, and bacterial loads in lavage fluid of contact mice are shown.
C. Age-matched wildtype and tlr2-/- pups were split into index and contact groups
and cross-fostered such that either the index were wildtype and the contacts were
tlr2-/- or that the index were tlr2-/- and the contacts were wildtype. The infection
scheme described in Figure 1A was then followed, and bacterial loads in nasal
lavage fluid are shown, with open symbols denoting index mice and filled
symbols representing contact mice. ** indicates p < 0.01 by Mann-Whitney test.

Figure 3. Influenza infection results in neutrophil influx to the
nasopharynx. Wildtype mice were infected as index mice with the listed agents.
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On day 14, mice were euthanized, and nasal lavage was performed with PBS. A.
A 100 µl sample of each lavage was analyzed by flow cytometry to detect total
numbers of neutrophils (Ly6G+, CD11b+). Each dot represents the percentage of
total events that were neutrophils per mouse. Statistical significance was assessed
using the Kruskal-Wallis test followed by Dunn’s post-test, and * indicates p <
0.05, while ** denotes p < 0.01. B. Immunofluorescence image (representative).
Ten microliter samples of nasal lavage fluid were spotted onto a glass slide, fixed,
and stained with DAPI (blue) and antibodies against Ly6B (green) and type 23F
pneumococcal capsule polysaccharide (red).

Figure 4. Mice deficient in TLR2 display increased inflammation and
increased viral titers following influenza infection. A. Mice of listed
genotypes were infected with specified agents, as above, and nasal lavage fluid
was stained and analyzed by flow cytometry. Percentage of total events staining
positive for neutrophils are shown, with each dot representing one mouse.
Asterisk denotes p < 0.05 using an unpaired Student’s t test. B-D. Wildtype
(black bars) and tlr2-/- (gray bars) mice were infected as index mice with either S.
pneumoniae and influenza or influenza alone as described in Figure 1A. Mice
were sacrificed on day 14 (day 11 for panel C), and following nasal lavage with
200 µl PBS, a second lavage with 600 µl RLT lysis buffer was performed, from
which RNA was then extracted. Quantitative real-time PCR was performed to
determine RNA levels of MUC5AC (B), IFN% (C), and influenza nucleoprotein
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(D). E. Wildtype mice were infected as index mice with S. pneumoniae and
influenza. For P3C treated mice (hatched bar), 10 µg of Pam3Cys was
administered intranasally on days 8, 10, and 12. RNA was extracted from nasal
lavages as described above, and levels of influenza nucleoprotein were assessed
by qRT-PCR. For B-E, fold change in tlr2-/- and P3C-treated mice relative to
wildtype was determined using the ""CT method with GAPDH as an endogenous
control. Bars indicate mean of 6 mice per condition (±SEM), and asterisks denote
statistically significant difference using Student’s t test (p < 0.05). F. Wildtype
mice were infected as index animals, and were given Pam3Cys intranasally on
days 8, 10, and 12, or left untreated. Flow cytometry analysis was performed on
stained nasal lavages, and total cells counts in 100 µl lavage fluid were
determined. Each dot represents one mouse, and statistical significance was
determined using a Mann-Whitney test, with ** denoting p < 0.01.

Figure 5. Influenza infection induces bacterial shedding at a level high
enough to infect infant mice. A-E. Wildtype (A, C, and E) and tlr2-/- mice (B
and D) were infected with either S. pneumoniae and influenza (A, B and E) or S.
pneumoniae alone (C and D) as described in Figure 1A. Each day (starting on day
8), the nose of each mouse was gently pressed onto an agar plate 10 times,
exhaled bacteria were spread, and plates were incubated overnight. Each symbol
represents the bacterial count from one animal on each day. In panel E, Pam3Cys
or PBS alone (vehicle control) was administered on days 8, 10 and 12. Colony
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counts from days 10 and 11 are combined for comparison. F. Infant (7 day old)
and adult (6 week old) mice were inoculated with ~500 (dotted line) CFU of
strain P1121 in PBS. One day post inoculation, the mice were sacrificed, nasal
lavage was performed and lavage fluid was serially diluted and plated on selective
media to enumerate bacteria.

Figure S1. Timing of pneumococcal acquisition does not affect
transmission to littermates. Index (inoculated contact) pups were inoculated
with S. pneumoniae on day 9 instead of day 4, but otherwise treated as detailed
in Figure 1A. For all panels, dotted line indicates limit of detection (50 CFU).
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CHAPTER 5:
Discussion: Inflammation in growth, immune evasion and
transmission
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Influenza-induced inflammation promotes pneumococcal growth
The predominance of pneumococcal disease following influenza infection has
been well-described, but the mechanisms underlying this association were
incompletely understood. We found influenza infection predisposed mice to
increased density of pneumococcal colonization 24 hours following bacterial
challenge. Influenza did not increase bacterial numbers 1 hour after
pneumococcal challenge, implying that the viral effects on bacterial numbers
were not due to increased bacterial adherence to the epithelium or mucus.

The effect of influenza on secondary bacterial challenge was maximal at 7 days
after viral inoculation, a timepoint after peak viral titers were reached. This
timepoint also reflected the peak in availability of sialic acid, the host metabolite
we identified as the nutrient source pneumococci exploited during influenza
infection. It was also the peak in mucin production and secretion onto the
mucosal surface of the upper respiratory tract, consistent with previous reports of
Muc5ac transcription during influenza infection of the lower respiratory tract
(14). These mucins are heavily glycosylated and served as a source of sialic acid
for colonizing pneumococci to exploit. We found no further increase in
pneumococcal density after 10-14 days of influenza infection (data not shown)
compared to 7 days of influenza infection. Consistent with this finding was a lack
of increase in sialic acid available in the upper airway after longer influenza
infections (data not shown). These results contrasted with previous findings
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measuring the kinetics of Muc5ac protein levels in the lungs of influenza-infected
mice that found mucin in the bronchoalveolar lavage fluid continued to increase
beyond 7 days of influenza infection (27). The relative levels of inflammation that
occur in these different anatomic sites could account for this discrepancy.

The timing of the effect we saw is also consistent with previous epidemologic data
(218). During the 1918 pandemic, most deaths due to secondary bacterial
pneumonia occurred 6-10 days after the onset of influenza infection (105).
Colonization of the upper respiratory tract is the prerequisite to pneumococcal
pneumonia, (19) and we found that higher densities of pneumococci colonizing
the nasopharynx correlated with increased bacterial numbers in the
bronchoalveolar lavage fluid and lung parenchyma. The risk of bacterial
aspiration and potential progression to overt disease, therefore, depends initially
on changes in bacterial density in the upper airway. Previous studies had noted
this association between upper and lower airway bacterial densities during
pneumococcal pneumonia in humans, (5) but it was previously unclear whether
higher bacterial numbers in the nasopharynx preceded those in the lungs or if
they were a function of higher bacterial growth in the lungs reseeding the upper
airway during pneumonia. Our results establish that, at least in mice, higher
upper airway bacterial density leads to higher lower airway bacterial density.
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In our studies, pneumococcal challenge followed influenza infection. In young
children and other populations where pneumococcal colonization is common,
colonization may precede, rather than follow, influenza infection, (47, 204)
though the mechanisms we describe by which influenza can promote bacterial
growth may also operate during concurrent influenza and pneumococcal
coinfection. The flow cytometric assay we developed can only measure bacterial
replication for a limited number of replication cycles before the fluorescence
levels have diluted to background levels. For technical reasons, therefore, we
could not directly test whether pneumococci that have already established
colonization begin to grow faster during secondary influenza infection.

Our studies focused on sialic acid, the terminal modification on mucins that were
therefore most accessible as a potential nutrient source for colonizing bacteria
(202). In the most common oligosaccharide chains decorating mucins that end in
sialic acid, the next most accessible carbohydrates are galactose and Nacetylglucosamine. Much like neuraminidases, pneumococci express
exoglycosidases specific for each of these underlying sugars and can catabolize
them as sole carbon sources (31, 101). While we observed an increase in sialic
acid availability in the nasopharynx during influenza infection, we saw no change
in the total reducing sugar content of the airway, which would include both
galactose and N-acetylglucosamine. Since the carbohydrate content of mucins
can be be up to 90% sialic acid, it is potentially unsurprising that the massive
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mucus secretion observed would not be accompanied by a major detectable
increase in galactose or N-acetylglucosamine levels. These less abundant sugars
would likely be more highely preferred carbon sources, however, as pneumococci
grow on each as a sole carbon source faster than on sialic acid alone in vitro (18).

We found Muc5ac, the dominant airway mucin secreted in response to
inflammatory stimuli, to be a significant source of sialic acid in vivo during
influenza-pneumococcal coinfection. There are other mucins present in the
airway, however, including Muc5b, a major constituent of the mucus layer at
baseline in the airway (202, 205). Muc5b has previously been shown to serve as a
nutrient source in vitro for oral bacteria (265). Alterations in the mucus layer due
to Muc5ac deletion could have effects on influenza infection, potentially
confounding our assessment of pneumococcal colonization following influenza
infection in these mice had the loss of mucins reduced viral load. Viral titers were
higher in Muc5ac-/- mice, however, (data not shown) which was consistent with a
previous report demonstrating that lung-specific overexpression of Muc5ac
attenuated influenza infection in mice (55).

Our work has potential clinical implications. We found both viral and bacterial
neuraminidases contributed to desialylation of host substrates in vivo, suggesting
that both could be important targets for pharmaceutical development. Currently
clinically used neuraminidase inhibitors are only effective against the influenza
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neuraminidase (165). A recent meta-analysis of neuraminidase inhibitor
randomized controlled trials in healthy adults has raised controversy over the
efficacy of these anti-influenza agents (87). Our results suggest that studies of
neuraminidase inhibitors using prevention of bacterial pneumonia, rather than
resolution of symptoms of the primary influenza infection, as the endpoint would
be important. Since influenza mortality is primarily from secondary bacterial
infections, preventing pneumonia is a more appropriate goal of therapy.
Targeting bacterial colonization in the upper airway could also prevent other
sequelae of influenza infection, such as pneumococcal otitis media (140).

There is precedent outside the respiratory tract for our findings that
inflammation promotes bacterial growth. Extensive work with Salmonella
enterica serotype Typhimurium demonstrated that these bacteria that induce
massive intestinal inflammation can evade this response and also exploit hostderived nutrients to promote growth (59). The host response to Salmonella
infection includes production of the antimicrobial protein lipocalin-2, which
binds to the bacterial iron chelator enterochelin, preventing gut commensal
bacteria from obtaining this vital nutrient. Salmonella that encode an alternative
chelator, salmochelin, are resistant to lipocalin-2 and can therefore evade this
host response (190). In other studies, Salmonella was found to induce host
production of reactive oxygen species, which serve an antimicrobial function but
also generate tetrathionate. Salmonella, but not resident members of the
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commensal flora, are able to respire on tetrathionate as a terminal electron
acceptor, allowing Salmonella to outcompete other gut bacteria (266).
Tetrathionate respiration permitted Salmonella to consume ethanolamine, a
nutrient source that could not be fermented in the normal anaerobic gut (235).
Intestinal inflammation also includes the generation of reactive nitrogen species,
which results in nitrate production. Commensal Escherichia coli can exploit this
nitrate to promote growth during chemically-induced colitis at the expense of
other commensal bacteria that cannot respire on this nutrient source (267).
These examples from the gastrointestinal tract demonstrate that bacteria at a
range of anatomic sites can exploit host inflammation to promote their own
growth, much as we found pneumococci take advantage of the host sialylated
mucin response during influenza-induced inflammation to accelerate sialic-acid
dependent pneumococcal replication.

Tonic inflammation in infancy delays clearance of colonization
Pneumococcal colonization is more common and prolonged in childhood, but the
mechanisms underlying these epidemiologic associations have been unclear. We
used a murine model of pneumococcal colonization and found that mice
inoculated as infants carried pneumococci longer than did mice inoculated as
adults. This effect was not due to differential localization of the bacteria within
the nasopharynx or different growth early during initiation of colonization,
suggesting the higher bacterial density was due to delayed clearance of
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colonization. Macrophages, the effector cells of pneumococcal clearance in adults,
were not recruited into the infant nasopharyngeal lumen until later on in the
course of colonization than in adult mice. Delayed recruitment was due to
increased tonic expression of the chemokine Ccl2, as ectopic Ccl2 overexpression
rescued the defects in macrophage recruitment and pneumococcal clearance.
Tonic Ccl2 expression was dependent on the presence of the commensal flora in
infant mice, and was present at distal, sterile sites, not only in the upper
respiratory tract epithelium. CCL2 protein levels were higher in infant serum
than adult. Using thioglycollate to elicit peritoneal macrophages, we examined
transcriptional responses in these phagocytes isolated from a site that lacks a
commensal flora. We found higher Ccl2 expression in unstimulated infant
macrophages compared to adults. Infant macrophages did not increase Ccl2
production in response to stimulation with heat-killed pneumococci, unlike adult
macrophages. Expression of Ccr2 was, correspondingly, lower in infants, though
this pattern was not seen for other cell surface receptors, including Marco and
Cd36. Levels of Il17a expression were also higher tonically in the infant upper
respiratory tract, suggesting a possible mechanism for the effects on Ccl2.

Our results suggest a potential model in which acquisition of the microbiota is
sensed by infant cells. This sensing may occur locally in the gut, upper respiratory
tract and other colonized surfaces, or could occur systemically, which is made
more possible in infant mice by the relative leakiness of the infant gut (195).
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Sensing of the commensal flora could occur through an IL17A-dependent
mechanism, as suggested by the increased Il17a expression found in the infant
nasopharynx. Previous reports have also suggested that infants are biased
towards Th17 cell development, (108) including producing primarily Th17-related
cytokines when whole blood was stimulated with TLR ligands, namely IL-6 and
IL-23 (41). A more Th17-biased infant may also lead to more CCL2 expression
(36, 210).

We found that infant mice do not respond to pneumococcal colonization with the
same inflammatory response as adult mice. Specifically, Ccl2 was not upregulated
during colonization of infants. The failure to induce Ccl2 led to delayed influx of
macrophages into the nasopharyngeal lumen. Inflammation was not completely
impaired in infants, however, as neutrophils entered the nasopharynx with the
same kinetics as in adult mice. Correspondingly, neutrophil chemoattractant
Mip2 was expressed at equal levels (data not shown). Anti-pneumococcal
antibody production was also equivalent between different aged mice. Not only
was inflammation was not impaired in infants, but in some ways was even greater
in infants, given the baseline higher expression of Ccl2, Ccl7 and Il17a in the
upper respiratory tract.

The altered inflammatory state of infant mice is interesting in light of the
increased susceptibility to infectious diseases found in human neonates (2).
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Antibiotic treatment of neonatal mice through the nursing dams resulted in a
decrease in the infant commensal flora, which caused a decrease in IL-17
production in the gut, G-CSF production systemically and neutrophil numbers,
(51) lending support to the possibility that IL-17 is responsible for the tonic
increase in infant CCL2 signaling. The microbiota, it appears, is important in
promoting neutrophilia of infancy, which prevents invasive sepsis. Another
recent study found that infant mice have elevated numbers of CD71+ erythroid
cells that have immunosuppressive effects due to arginase-2 expression (57).
These cells contributed to the immunocompromised state of infants, specifically
including susceptibility to infections with Listeria monocytogenes and E. coli.
The normal purpose of these cells seemed to be preventing excess inflammation
in response to the sudden acquisition of a commensal flora in newborns, as
inflammatory cytokine production increased when infant immune cells were
treated with anti-CD71 antibody (57). These effects were limited to the gut,
however, and not other anatomical sites where there was no commensal flora
being newly acquired in infancy (57). The tonic expression of Ccl2 in the infant
nasopharynx could have similar effects preventing inflammation in response to
harmless commensals of the upper respiratory tract. Inflammation of infancy in
response to the commensal flora, therefore, can be exploited by the opportunistic
pathogen S. pneumoniae to evade clearance on the mucosal surface. In the
respiratory tract, previous work has shown that invasive bacterial pathogens,
including pneumococci can benefit from TLR-mediated opening in the epithelial
157

barrier, allowing bacteria to evade mucosal immunity by entering the systemic
circulation (40).

Inflammation influences pneumococcal transmission
Transmission of pneumococci from one host to another initiates the process of
colonization, and is required for pneumococcal disease (19). The mechanisms
underlying this critical process, however, have been poorly understood (52, 94).
Pneumococcal transmission occurs by transfer of respiratory secretions from a
colonized host to a naive one, or at least to a host not colonized with that
particular strain (113). Transmission within families has been shown to coincide
with upper respiratory tract infections, (68) and colonization is temporally
associated with viral upper respiratory tract infections (251) and is more common
in children (65). We therefore studied transmission between infant mice within
litters, with or without influenza infection. Transmission from directly inoculated
“index” mice to uninoculated “contact” pups only occurred during influenza
infection, consistent with previous reports (52, 217).

Investigating the host factors responsible for pneumococcal transmission, we
found that Tlr2-/- mice had increased transmission compared to wildtype litters.
This effect was specific to the genotype of the index mice, with Tlr2-/- index mice
promoting high rates of transmission even to wildtype contact pups in mixedlitter cross-fostering experiments. Further experiments with wildtype mice and
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Pam3Cys, a TLR2 agonist, demonstrated that signaling through TLR2 limits
pneumococcal transmission. Initially, these results seemed to suggest that
inflammation would protect against pneumococcal transmission from index mice
to uninoculated contact mice. Mice lacking Tlr2, however, had equivalent levels
of pneumococcal colonization in index mice to wildtype, suggesting that the
TLR2-dependent inflammatory response during colonization of coinfected
infants did not have any effect on clearing carriage. A closer look at the nasal
lavages of these mice indicated that Tlr2-/- index mice did not necessarily have
less inflammation. In fact, influenza-pneumococcus coinfected index mice that
lacked Tlr2 recruited even more neutrophils into the nasopharynx, and had
increased production of the secreted airway mucin Muc5ac, both suggestive of
enhanced rather than limited inflammation in these mice. Expression of type I
interferons was decreased in the absence of Tlr2, however, suggesting that the
host response to influenza was not completely intact. Inflammatory responses
cannot all be grouped together and knockout mice simply described as being
more or less inflamed, as these data make clear. TLR2 signaling altered the
inflammatory response to influenza, thereby limiting viral titers as measured by
quantitative reverse transcriptase PCR. Increased viral titers in Tlr2-/- index mice
were associated with higher pneumococcal shedding from the same mice, which
promoted transmission. Overall, these data led to a model in which TLR2 signals
lead to a specific anti-influenza inflammatory response that limits viral
replication. Without these responses, potentially including type I interferons,
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influenza replication is left unchecked, which is associated with an altered
inflammatory response that includes excess neutrophil recruitment and mucin
production. These last two elements of the host response could potentially aid in
transmission, through as yet unknown mechanisms.

There is existing evidence that inflammation aids in pneumococcal transmission
(217). This study found that inoculating contact mice with lipopolysaccharide
(LPS) can replace influenza as an inflammatory stimulus in contact mice,
rendering them susceptible to acquiring pneumococci during transmission. LPS
treatment had no effect on increasing transmission from index mice that were not
infected with influenza, however (217). These results, combined with our findings
regarding the genotype of index versus contact mice, suggest that different stages
of transmission may have different interactions with the host response to
inflammatory stimuli. TLR2-mediated effects on viral replication appear to
increase pneumococcal shedding from index mice, while LPS, through some
unknown mechanism, alters the host environment in contact mice to predispose
them to acquiring pneumococcal colonization during transmission. Whether
these LPS-treated mice are also more susceptible to higher pneumococcal titers
when directly inoculated experimentally has not been determined, and it is
therefore possible that the effects of LPS on the contact mice do not reflect any
impact on the act of transmission itself, but rather on bacterial behavior after
establishing colonization. Given our results with inflammation promoting
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bacterial growth, it is possible that LPS could have a similar effect once bacteria
have reached the nasopharynx.

Even with influenza coinfection, we only observed transmission between infant
mice, not adults. There are several possible explanations for this phenomenon. It
may be that the vector of transmission is not direct nose-to-nose contact, but
rather deposition of respiratory secretions containing shed pneumococci onto the
teats of the nursing dam, which are then acquired by previously uninoculated
contact mice. Also possible is that infant mice have much closer contact with one
another, even outside the nursing dam, than do adult co-housed mice. Infant
mice may have altered susceptibility to colonization (acquiring transmission as a
contact mouse) or shedding (initiating transmission as an index mouse), or even
altered responses to influenza, which could impact the inflammation necessary
for transmission. We found that the colonizing dose at which infant mice become
stably colonized is orders of magnitude lower than for adult mice, suggesting that
infant mice are more susceptible to acquiring pneumococci during transmission.
This result is consistent with the previously described higher levels of
colonization in human infants relative to adults (81).

Future directions
Our work opens several new avenues for further studies. We found that the host
mucin response to influenza infection predisposes infected mice to secondary
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pneumococcal colonization by providing a nutrient source. We observed
increased numbers of bacteria reaching the lower respiratory tract in influenzainfected mice, the prerequisite for pneumonia. We have not yet, however,
determined that influenza-mediated provision of sialic acid to colonizing
pneumococci does lead to increased risk of pneumococcal pneumonia. Use of a
more invasive strain that can more readily cause pneumonia in mice could be
helpful in these experiments (112, 137). It would also be important to study the
role of influenza-mediated pneumococcal growth in promoting other secondary
bacterial infections, such as acute otitis media (216).

Future studies could also broaden the phenotype we described to other pathogens
implicated in secondary bacterial pneumonia. The most common bacteria
isolated in these patients, after pneumococci, are Haemophilus influenzae and
Staphylococcus aureus. Both are capable of catabolizing sialic acid in vitro, (170,
248) suggesting the mechanism we observed in pneumococci may apply to these
other extracellular respiratory pathogens as well. It may not be straightforward to
pursue these experiments from a technical perspective, however. Most strains of
S. aureus colonize the mouse upper respiratory tract poorly, (9) potentially
making it difficult to model increased colonization following influenza. In
addition to catabolizing it, H. influenzae also displays sialic acid on its surface to
avoid recognition from the host immune system, (248) complicating experiments
aimed at uncovering the role of influenza-provided sialic acid in promoting
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growth of that bacterium. As technically challenging as these experiments could
be, they could reveal a common mechanism that would explain why only a certain
subset of bacteria cause post-influenza disease (106). Interestingly, only bacteria
that interact with an animal host during their lifestyle, as opposed to free-living
bacteria, contain genes for sialic acid catabolism, suggesting the ability to utilize
this sugar evolved as a part of interacting with hosts (6). Studying viruses other
than influenza A could also be instructive in understanding secondary bacterial
pneumonia. Parainfluenza viruses have also been found to predispose to
pneumococcal colonization in epidemiologic studies, interesting in light of both
parainfluenza and influenza viruses expressing neuraminidase activity (66). It is
possible, however, that the enzymatic ability of these viruses to release sialic acid
into the nasal lumen is not the relevant aspect of their biology that predisposes to
secondary bacterial disease mediated by sialic acid-dependent growth. Rather,
these viruses may solely induce host secretion of sialylated mucins, with only
bacterial neuraminidases necessary for pneumococci to obtain sialic acid as a
carbon source. One way to distinguish between these possibilities would be the
use of a respiratory virus that does not contain a neuraminidase, but could be
engineered to express one. Pneumonia virus of mice does not depend on
neuraminidase activity for replication, so introduction of this gene would allow
for the clear delineation of the effects of neuraminidase activity on an otherwise
unchanged viral infection (203).
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Another important avenue for exploration would be whether the phenotype of
inflammation-provided sialic acid promoting pneumococcal replication even
requires a viral infection at all. Sterile inflammatory mediators, such as LPS or
other ligands of pattern recognition receptors, could be inoculated into mice to
determine whether these stimuli promoted sialic acid availability and subsequent
bacterial growth. In addition to acute mediators of inflammation, we could study
whether chronic airway inflammation predisposes to pneumococcal growth, as
asthma has been shown to be a risk factor for pneumococcal colonization in
humans (34). Though mouse models of allergic asthma do induce airway
hyperresponsiveness and mucus production, mimicking human disease, they are
limited in the lower respiratory tract, where inflammation may have different
effects on pneumococcal growth (149).

The timing of inflammatory stimulus, whether it is influenza infection or not,
relative to pneumococcal colonization may be interesting to study. The
fluorescence dilution method using CFSE staining was limited to measuring less
than 24 hours of replication in vivo since after several rounds of division the
amount of fluorescence per cell had decreased to background levels, making it
impossible to resolve more growth. To study longer term growth, or to allow for
bacterial inoculation prior to an inflammatory stimulus, other methods could be
used. Plasmid segregation assays have been described in pneumococci (245) and
other bacteria (152, 227) to measure replication in vivo. Single-copy plasmids
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that do not replicate at temperatures encountered in vivo can be introduced into
the bacteria of interest. Each cell division in vivo reduces by half the proportion
of bacteria carrying the plasmid, which expresses a selectable antibiotic
resistance marker.

We studied the inflammation present at baseline in the infant nasopharynx, and
found the response to commensal bacteria delays clearance of pneumococcal
colonization. Our work did not establish where commensal bacteria are sensed to
promote increased Ccl2 expression, however. This effect could be entirely local,
with the upper respiratory tract commensal flora stimulating an inflammatory
response in the URT epithelium. Arguing against this possibility is the evidence
that CCL2 signaling is altered even in sterile sites such as the serum and
peritoneal cavity. Instead, it is possible that the effect of the flora on Ccl2
expression is a systemic process. Bacteria or bacterial products may enter the
circulation through the leaky gut of infancy, (195) with sensing occurring in the
gut, nasopharynx or potentially elsewhere. Plasma endotoxin levels have been
found to correlate with intestinal permeability in mice and an altered gut
microbiota (33). Even in the absence of a leaky gut, peptidoglycan from the
commensal flora can be found in adult mice systemically, leading to priming of
neutrophil defenses (39).
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Our work focused on how inflammation alters infant susceptibility to
pneumococcal colonization, but future studies could examine how it predisposes
infants to other diseases. Children are also more likely than adults to be colonized
with H. influenzae or Moraxella catarrhalis, (180) which both colonize the
nasopharynx and cause acute otitis media, susceptibility to either of which could
be altered in infancy by the tonic expression of macrophage chemoattractants.
The processes we described may also influence infant susceptibility to invasive
infections, stemming from the respiratory tract or elsewhere. Listeria
monocytogenes would be particularly important to study, both as a significant
pathogen in neonatal sepsis and as an infection whose clearance depends on
CCL2-mediated monocyte trafficking (57, 208, 214). Characterizing the full set of
chemokines and cytokines with altered expression in infancy would be important
in selecting future directions of study.

Studies on pneumococcal transmission are far from complete, with many more
host and bacterial factors responsible for influencing this process yet to be
discovered. These studies identified that the inflammatory response to influenza
increased pneumococcal transmission between infant mice, especially when
directly inoculated “index” mice were deficient in TLR2 signaling. Exactly what
aspect of the inflammatory response is responsible for increased transmission,
potentially due to increased bacterial shedding, remains to be described.
Bacteria-containing respiratory secretions stimulated by mucus production could
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contribute to bacterial spread, particularly among children, who have poor levels
of hygiene (155). If the effects of TLR2 signaling are mediated solely through
suppressing influenza viral titers, it will be important to determine whether any
method of increasing influenza titers in index mice would lead to increased rates
of transmission, or vice versa. Similarly, any method of inflaming the index
mouse could substitute for influenza or other respiratory viral infection. A
previous report indicated that LPS treatment only increased transmission when
given to contact mice, not index mice, (217) but this study did not examine
bacterial shedding. It is possible that LPS had no effect on shedding, the relevant
benefit inflammation may provide to transmission from index mice, explaining
its lack of effect on index mice.

Conclusions
Inflammation has been described for millenia, with 1st century Roman physician
Cornelius Celsus first denoting the four clinical symptoms that classically
characterize acute inflammation in response to injury or infection: rubor
(redness), tumor (swelling), calor (heat) and dolor (pain) (145). Since Celsus, the
cellular and molecular underpinnings of these effects have been described, and
the definition of inflammation itself has been broadened to reflect its multiple
forms, triggered by a range of stimuli. These stimuli do not have to cause damage,
and inflammation is now thought to be an extension of homeostatic responses
(37). Still, at its core inflammation is the body’s attempts to return to a baseline
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state, even if that does not occur until inflammation is resolved. Colonization by
opportunistic bacterial pathogens represents one such challenge to homeostasis
that is countered by an acute inflammatory response (17, 176). We hypothesized
that certain bacteria, such as the pneumococcus, can take advantage of
inflammation to gain an advantage during airway colonization.

There is precedent for the hypothesis that inflammation promotes pneumococcal
colonization. In mice, pneumococci that lack the pore-forming toxin
pneumolysin, and therefore are less capable of inducing an inflammatory
response, are attenuated in early colonization compared to wildtype pneumococci
(93, 246). Human patients with chronic inflammatory disease are at increased
risk for invasive pneumococcal disease, (268) and chronic inflammatory diseases
of the respiratory tract such as asthma and Chronic Obstructive Pulmonary
Disease (COPD) predispose to higher rates of pneumococcal colonization (34,
73). Influenza infection increases pneumococcal colonization in experimental
settings, (252) and clinical studies have shown that pneumococcal colonization is
temporally associated with viral upper respiratory tract infections (68, 99, 194,
251). Increased mucus secretions, furthermore, correlate with higher density of
pneumococcal colonization in children (198).

In these studies, we found inflammation promotes three separate steps in
pneumococcal colonization. The inflammatory mucin secretion response to
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influenza infection primes the host for rapid pneumococcal growth in the
otherwise harsh environment of the nasopharynx (181). Sialylated mucin
secretion also occurred to a lesser extent during colonization in the absence of
influenza. Colonization can be thought of as adaptation to a new niche to obtain a
source of nutrients other bacteria are unable to acquire, (25, 200) and
inflammation induced by colonizing pneumococci or coinfection represents a
distinct niche pneumococci have evolved to exploit. We also found that
inflammation in the infant nasopharynx in the form of tonic expression of Ccl2
and Ccl7, two important macrophage chemoattractants, predisposes neonates to
pneumococcal colonization. Here, inflammation that is misdirected against the
commensal flora allows pneumococci to evade innate immune clearance,
persisting on the mucosal surface. Lastly, we found that inflammation during
influenza infection allows for pneumococcal transmission between infant mice.
Together, these results demonstrate the multiple, distinct ways colonizing
pneumococci have evolved to exploit the same host responses meant to combat
this opportunistic pathogen.
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